Antidiabetic and Toxicity Assessment of Combination of Piper

Nigrum and Artocarpus Hetropyllus by Mohammed Haleel, P M
ANTIDIABETIC AND TOXICITY ASSESSMENT OF COMBINATION OF PIPER 
NIGRUM AND ARTOCARPUS HETROPYLLUS 
 
 
 
A Dissertation submitted to  
THE TAMIL NADU Dr.M.G.R. MEDICAL UNIVERSITY  
CHENNAI - 600 032 
 
 
In partial fulfillment of the requirements for the award of the Degree of 
MASTER OF PHARMACY 
IN 
PHARMACOLOGY 
 
 
 
Submitted by 
 
MOHAMMED HALEEL P.M 
Reg no: 261425663 
 
 
Under the guidance of 
 
Dr. C.SENTHIL KUMAR M. Pharm., PGDCR., PhD. 
Department of Pharmacology 
 
 
 
 
 
 
 
R.V.S College of Pharmaceutical Sciences 
Sulur, Coimbatore – 641 402, 
 TAMILNADU 
 
OCTOBER 2016 
 
 
 Certificate 
This is to certify that the dissertation work entitled “ANTIDIABETIC AND TOXICITY 
ASSESSMENT OF COMBINATION OF PIPER NIGRUM AND ARTOCARPUS 
HETROPYLUS” is a bonafide work done by MOHAMMED HALEEL.P.M (Reg No: 
261425663) under my guidance for the partial fulfillment for the award of degree of 
Master of Pharmacy in Pharmacology, at Department of Pharmacology, RVS College of 
Pharmaceutical Sciences, Sulur, Coimbatore, affiliated to The Tamilnadu Dr. M.G.R 
Medical University, Chennai. 
 
 
 
 
                                                     Dr. C.SENTHIL KUMAR M. Pharm., PGDCR., PhD. 
                                                     Lecturer 
                                                     Department of Pharmacology 
                                                     RVS College of Pharmaceutical Sciences 
                                                     Sulur, Coimbatore-641402 
 
 
 
 
Date: 
Place: Coimbatore  
  
 Certificate 
This is to certify that the dissertation work entitled “ANTIDIABETIC AND 
TOXICITY ASSESSMENT OF COMBINATION OF PIPER NIGRUM AND 
ARTOCARPUS HETROPYLUS” is a bonafide work done by MOHAMMED 
HALEEL.P.M (Reg No: 261425663) under the direct guidance of Dr. C. SENTHIL 
KUMAR M.PHARM., PGDCR., PhD in partial fulfillment for the award of degree of 
Master of Pharmacy in Pharmacology, at  department of Pharmacology, RVS college of 
Pharmaceutical sciences, Sulur, Coimbatore, affiliated to The Tamilnadu Dr. M.G.R 
Medical University, Chennai. 
 
 
 
 
                                                                    Dr. D. BENITO JOHNSON M.Pharm., Ph.D. 
                                                                    Professor and Head 
                                                                    Department of Pharmacology 
                                                                    RVS College of Pharmaceutical Sciences 
                                                                    Sulur, Coimbatore -641402 
 
 
 
Date: 
Place:  Coimbatore  
  
Certificate 
This is to certify that the dissertation work entitled “ANTIDIABETIC AND 
TOXICITY ASSESSMENT OF COMBINATION OF PIPER NIGRUM AND 
ARTOCARPUS HETROPYLUS” is a bonafide work  done by MOHAMMED 
HALEEL.P.M (RegNo:261425663)  under the direct guidance of Dr. C. SENTHIL 
KUMAR M.PHARM, PGDCR, PhD in  partial fulfillment for the award of degree of 
Master of Pharmacy in Pharmacology, at department of Pharmacology, RVS college of 
Pharmaceutical sciences, Sulur, Coimbatore, affiliated to The Tamilnadu Dr. M.G.R 
Medical University, Chennai. 
 
 
 
                                                          Dr. R. VENKATANARAYANAN M.Pharm., Ph.D. 
                                                          Principal 
                                                          RVS College of Pharmaceutical Sciences 
                                                          Sulur, Coimbatore-641402 
 
 
 
Date: 
Place: Coimbatore  
  
Certificate 
This is to certify that the dissertation work entitled “ANTIDIABETIC AND 
TOXICITY ASSESSMENT OF COMBINATION OF PIPER NIGRUM AND 
ARTOCARPUS HETROPYLUS” is a bonafide work by MOHAMMED HALEEL.P.M 
(Reg No: 261425669) Department of Pharmacology RVS college of Pharmaceutical 
sciences, Sulur, Coimbatore, in partial fulfillment of the University rules and regulations 
for the award of Master of Pharmacy in Pharmacology under my guidance and supervision 
during the academic year 2015-16. 
Mr. C. SENTHIL KUMAR M.Pharm., PGDCR., PhD. 
Lecturer 
Department of pharmacology 
R. V.S College of pharmaceutical sciences 
Sulur, Coimbatore 
 
Dr. D. BENITO JOHNSON M.Pharm., Ph.D. 
Professor and Head 
Department of Pharmacology  
R.V.S College of Pharmaceutical Sciences 
Sulur, Coimbatore 
 
Dr. R.VENKATANARAYANAN M.Pharm., Ph.D. 
Principal 
RVS College of Pharmaceutical Sciences, 
Sulur, Coimbatore-641402 
  
Evaluation Certificate 
 
Dissertation title                  :  ANTIDIABETIC AND TOXICITY 
ASSESSMENT OF COMBINATION OF PIPER 
NIGRUM AND ARTOCARPUS HETROPYLLUS 
Name of the Candidate      :            MOHAMMED HALEEL .P.M  
                                                          (Reg No: 261425663) 
Course of Study             :         Master of Pharmacy in Pharmacology 
Institution Name            :         RVS College of Pharmaceutical Sciences, Sulur,  
                                                           Coimbatore                                                   
 
 
              
 
 
 
 
 
INTERNAL EXAMINER                                                 EXTERNAL EXAMINER  
 
 
 
 
Date:  
Place: 
 
 
Declaration 
I hereby declare with immense pleasure and satisfaction that this dissertation work entitled 
“ANTIDIABETIC AND TOXICITY ASSESSMENT OF COMBINATION OF 
PIPER NIGRUM AND ARTOCARPUS HETROPYLUS” was carried out by me under 
the guidance of Dr. C.SENTHIL KUMAR M.Pharm., PGDCR., PhD. lecturer Department 
of Pharmacology, RVS College of Pharmaceutical Sciences, Sulur, Coimbatore. 
                
 
                                                                          MOHAMMED HALEEL P.M 
                                                                           Reg.No:  261425663 
                                                                           II. M.Pharm 
                                                                           Department of Pharmacology 
                                                                           R.V.S College of Pharmaceutical Sciences. 
                                                                           Sulur, Coimbatore-641402. 
 
Date: 
Place: Coimbatore. 
 
 
 
 
 
 
 
 
ACKNOWLEDGEMENT 
 First of all, I would like to extend my sincere gratitude to God Almighty, whose 
divine intervention was instrumental in the successful completion of this project work. 
There are a number of people whom I consider of this simple anthology and to whom I 
owe so much. 
I would like to express my whole hearted gratitude to MY FAMILY and MY 
FRIENDS without whose support and blessings, this endeavor would not have been 
completed. 
It is a great pleasure to acknowledge my sincere and deep sense of gratitude to my 
respected guide  Dr. C.SENTHIL KUMAR M. Pharm, PGDCR, PhD of department of 
pharmacology, RVS College of Pharmaceutical Sciences, Sulur, Coimbatore, for his 
invaluable guidance, help, suggestions and the confidence that he has shown in me 
throughout the course of my work. 
 I express my sincere gratitude to Dr. D. BENITO JOHNSON M.Pharm, PhD 
Department of Pharmacology, RVS College of pharmaceutical sciences, Sulur, 
Coimbatore, for his help and guidance throughout the completion of my work. 
I sincerely thank Dr. R. VENKATANARAYANAN, M.Pharm., Ph.D, 
Principal, RVS College of pharmaceutical sciences, Sulur, Coimbatore, for his 
inspirations and being a great facilitator. 
I am grateful to Mr. SAKTHIVEL, Mr.SURESH, Dr. W.D. SAM SOLOMON, 
Miss.SATHYA, Miss. ASHWINI and all the teachers and non teachers of my college for 
their meticulous guidance and encouragement provided to me for the completion of my 
dissertation work. 
However, it would not have been possible to complete my work without kind 
support and help of all my friends especially RASHID.K, SHRUTI RAMESH 
TIMANE, BANSHONGDOR H MAWLIEH, TIMAI PASSAH, SANDEEP.M, 
SABITH, ROLLY. 
As a final word, I would like to extend my sincere thanks to each and every 
individual who have been a source of support and helped me to complete my dissertation 
work successfully. 
                                                                                                   
                                                                                 MOHAMMED HALEEL P.M 
 
 ABSTRACT 
In the present study the combination of ethanolic leaf extract of Piper nigrum and 
Artocarpus hetrophyllus in the ratio 1:1 were administered orally to study the toxicity and 
antidiabetic effects. 
Acute toxicity studies on the albino rats show no morality at a dose of 2000mg/kg, during 
a time period of 14 days. NOAEL were not seen in the entire study period  
In-vivo sub-acute oral toxicity study were performed to evaluate the toxicities of 28 days 
by continuous administration of the prepared extract and no animal mortalities were 
observed in any of the study groups throughout the study period For all the dose level 
falling in the category NOAEL <100 mg/kg. The observations indicated that long-term 
administration of the extract had no adverse effects on the general health of the animals. 
No significant differences were observed in body weights or food consumption of the 
animals. Hence this preparation can be utilized clinically. 
The animals were induced diabetic with STZ at a dose of 60mg/kg intraperatoneal and the 
diabetic animals were treated with extract at a dose of 200mg/kg along with standard drug 
glibenclanide for 28 days orally. The serum glucose, body weight were measured which 
showed significantly increase when compared with positive control group.   
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DIABETES MELLITUS 
1. INTRODUCTION 
The Diabetes Mellitus is being one of five leading causes of deaths and debilitating disease in the 
world. One hundred and fifty million people were suffering from diabetes wide reaching, which is 
almost five times more than the estimates one decade ago and it may double in the year 2030 [1]. 
The development of diabetic complications is a major cause of morbidity and mortality and is an 
ever-increasing burden to healthcare authorities in both developed and developing nations. 
Epidemiological studies have confirmed that hyperglycemia is the most important factor in the 
onset and progress of diabetic complications [2]. 
 
 Diabetes mellitus or simply diabetes is a chronic metabolic disorder of carbohydrate, lipid and 
protein metabolism characterized by hyperglycemia, glycosurea, hyperlipidemia, negative 
nitrogen balance and sometimes ketonemia due to insufficient or complete cessation of insulin 
synthesis or secretion and/or peripheral resistance to insulin action [3]. The hallmark of diabetes 
mellitus is polyuria-excessive urine production, polydipsia-excessive thirst and polyphagia-
excessive eating [4]. 
 
 Diabetes is a condition primarily defined by the level of hyperglycaemia giving rise to risk of 
microvascular damage (retinopathy, nephropathy and neuropathy). It is associated with reduced 
life expectancy, significant morbidity due to specific diabetes related microvascular complications, 
increased risk of macrovascular complications (ischaemic heart disease, stroke and peripheral 
vascular disease), and diminished quality of life[5]. 
 
 The pathogenesis of diabetes mellitus and its complications is managed by insulin and oral 
administration of hypoglycemic drugs such as sulfonylureas and biguanides [6]. However, on 
chronic usage most of these agents produced several side effects, including hypoglycemic coma, 
insulin resistance, hyper-sensitivity, cholesterol, jaundice, abdominal pain, anorexia and metallic 
taste [4].  
For various reasons in recent years, the popularity of herbal medicines in diabetic control has 
increased. Natural plant drugs are frequently considered to be less toxic with lower side effects 
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than synthetic ones [7].Therefore searching herbal product with anti diabetic activity possessing 
fewer side effects receives considerable publicity and provides an opportunity to cure this disease 
[8]. 
EPIDEMIOLOGY 
The worldwide prevalence of DM has risen dramatically over the past two decades, from an 
estimated 30 million cases in 1985 to 285 million in 2010. Based on current trends, the 
International Diabetes Federation projects that 438 million individuals will have diabetes by the 
year 2030 (Fig. 1). Although the prevalence of both type 1 and type 2 DM is increasing worldwide, 
the prevalence of type 2 DM is rising much more rapidly, presumably because of increasing 
obesity, reduced activity levels as countries become more industrialized, and the aging of the 
population. In the most recent estimate for the United States (2010), the Centers for Disease 
Control and Prevention (CDC) estimated that 25.8 million persons, or 8.3% of the population, had 
diabetes ( 27% of the individuals with diabetes were undiagnosed). Approximately 1.6 million 
individuals (>20 years) were newly diagnosed with diabetes in 2010. DM increases with aging. In 
2010, the prevalence of DM in the United Sates was estimated to be 0.2% in individuals aged <20 
years and 11.3% in individuals aged >20 years. In individuals aged >65 years, the prevalence of 
DM was 26.9%. The prevalence is similar in men and women throughout most age ranges (11.8% 
and 10.8%, respectively, in individuals aged >20 years). Worldwide estimates project that in 2030 
the greatest number of individuals with diabetes will be aged 45–64 years. [9] 
 
Figure 1:-Worldwide prevalence of diabetes mellitus. Comparative prevalence (%) of estimates 
of diabetes (20–79 years), 2010 
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Presently as many as 50% of people with diabetes are undiagnosed. Since therapeutic intervention 
can reduce complications of the disease, there is a need to detect diabetes early in its course. The 
risk of developing Type 2 diabetes increases with age, obesity, and lack of physical activity. Its 
incidence is increasing rapidly, and by 2030 this number is estimated to almost around 552 million 
[10, 11]. Diabetes mellitus occurs throughout the world, but is more common (especially type 2) in 
the more developed countries, where the majority of patients are aged between 45 and 64 years. 
The greatest increase in prevalence is, however, expected to occur in Asia and Africa, where most 
patients will probably be found by 2030 [11] (Table 1). It is projected that the latter will equal or 
even exceed the former in developing nations, thus culminating in a double burden as a result of 
the current trend of transition from communicable to non-communicable diseases [12,13] 
 
Table 1:- List of countries with the highest numbers of estimated cases of diabetes for 2000 and 
2030[11]. 
                                         
                             2000 
 
                  2030 
 
 
Ranking 
 
 
Country 
 
People with 
diabetes (millions) 
 
 
Country 
 
 
 
People with 
diabetes (millions) 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
India                                                   
China 
U.S.                                                           
Indonesia 
Japan                                                      
Pakistan 
Russian Federation 
Brazil 
Italy 
Bangladesh 
                                                          
31.7
20.8 
17.7
8.4 
6.8
5.2 
4.6 
4.6 
4.3 
3.2 
India 
China 
U.S. 
Indonesia 
Pakistan 
Brazil 
Bangladesh 
Japan 
Philippines 
Egypt 
79.4 
42.3 
30.3 
21.3 
13.9 
11.3 
11.1 
8.9 
7.8 
6.7 
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CLASSIFICATION OF DIABETES MELLITUS 
The classification of diabetes mellitus has been a major discussion point over the last few years. It 
has been increasingly recognized that the old classification system based upon a patient’s 
dependence on insulin was misleading; under the old system patients were either classified as 
   
 Insulin Dependent Diabetes Mellitus (IDDM)  
 Non - Insulin Dependent Diabetes Mellitus (NIDDM). 
 
 In 1998, a new classification system based upon the etiological factors at work in diabetes was 
proposed by the WHO and it is listed below: this has now become the accepted system for 
classifying diabetes mellitus [14]. 
ETIOLOGIC CLASSIFICATION OF DIABETES MELLITUS 
Assigning a type of diabetes to an individual often depends on the circumstances present at the 
time of diagnosis, and many diabetic individuals do not easily fit into a single class [23] 
 
 
I. Type 1 Diabetes Mellitus 
 
 
 Autoimmune 
 Idiopathic 
 
 
             II. Type 2 Diabetes Mellitus 
 
 
 Relative Insulin Deficiency 
 Disorders Of Insulin Secretion 
 Insulin Resistance 
 
        
 
          III. Other Specific Types Of Diabetes  
                              Mellitus                                                     
 
 
 Genetic Defects In β-Cell Function 
        * Chromosome 12, HNF-1α (MODY 3) 
        * Chromosome 7, glycosidase (MODY 2) 
        * Chromosome 20, HNF-4α (MODY 1) 
        * Mitochondrial DNA 
        * Monogenic diabetes 
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  Genetic Defects In Insulin Action 
        * Type A insulin resistance 
        * Leprechaunism 
        * Rabson-Mendenhall syndrome 
        * Lipotrophic diabetes 
 Disease Of The Exocrine Pancreas 
        * Pancreatitis 
        * Pancreatectomy/trauma 
        * Neoplasia 
        * Cystic fibrosis 
        * Hemochromatosis 
        * Fibrocalcific pancreatopathy 
 Endocrinopathies 
        * Acromegaly 
        * Cushing syndrome        
        * Glucagonoma 
        * Pheochromocytoma 
        * Hyperthyroidism 
        * Somatostatinoma 
        * Aldosteronoma 
 Pharmacologically/Chemically 
Induced 
        * Vacor 
        * Pentamidine 
        * Nicotinic acid 
        * Glucocorticoids 
        * Thyroid hormones 
        * β-adrenergic agonists 
        * Tiazides 
        * α interferon 
  Infections 
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        * Congenital rubeola 
        * Cytomegalovirus 
 Infrequent Forms Of Autoimmune 
Diabetes 
        * Stiff-man syndrome) 
        * Antibodies against insulin receptors 
 Other Syndromes Occasionally 
Associated With Diabetes 
        * Down syndrome 
        * Klinefelter syndrome 
        * Turner syndrome 
        * Wolfram syndrome 
        * Friedreich ataxia 
        * Huntington’s chorea 
        * Lawrence-Moon-Biedel syndrome 
        * Myotonic dystrophy 
        * Porphyria 
        *Prader-Willi syndrome 
 
IV. Gestational diabetes mellitus 
 
 
Occurs in mostly in women during gestation. 
 
 
Table 2:- Etiologic Classification of Diabetes Mellitus. Adapted from WHO and ADA [17, 18, 13] 
 
i. Type 1 diabetes mellitus: 
 An autoimmune disease in which the immune system mistakenly destroys the insulin-making beta 
cells of the pancreas. It typically develops more quickly than other forms of diabetes. It is usually 
diagnosed in children and adolescents, and sometimes in young adults. To survive, patients must 
administer insulin medication regularly. Type 1diabetes used to be called juvenile diabetes and 
insulin-dependent diabetes mellitus (IDDM). However, those terms are not accurate because 
children can develop other forms of diabetes, adults sometimes develop type 1, and other forms of 
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diabetes can require insulin therapy. A variation of type 1 that develops later in life, usually after 
age 30, is called latent autoimmune diabetes of adulthood (LADA). Sometimes patients with 
autoimmune diabetes develop insulin resistance because of weight gain or genetic factors. This 
condition is known as double diabetes. 
 
ii. Type 2 diabetes mellitus 
 A disorder of metabolism, usually involving excess weight and insulin resistance. In these 
patients, the pancreas makes insulin initially, but the body has trouble using this glucose-
controlling hormone. Eventually the pancreas cannot produce enough insulin to respond to the 
body’s need for it. Type 2 diabetes is by far the most common form of diabetes, accounting for 85 
to 95% of cases in developed nations and an even higher percentage in developing nations, 
according to the International Diabetes Federation. This disease may take years or decades to 
develop. It is usually preceded by pre diabetes, in which levels of glucose (blood sugar) are above 
normal but not high enough yet for a diagnosis of diabetes. People with pre diabetes can often 
delay or prevent the escalation to type 2 diabetes by losing weight through improvements in 
exercise and diet, as the Diabetes Prevention Program and other research projects have 
demonstrated. Type 2 diabetes used to be called adult-onset diabetes and non-insulin-dependent 
diabetes mellitus (NIDDM). Those terms are not accurate because children can also develop this 
disease, and some patients require insulin therapy. 
 
iii. Other specific type (Monogenic diabetes) 
Diabetes caused by another condition. The many potential sources of secondary diabetes range 
from diseases such as pancreatitis, cystic fibrosis, Down syndrome and hemochromatosis to 
medical treatments including corticosteroids, other immunosuppressives, diuretics and 
pancreatectomy. 
 
iv. Gestational Diabetes Mellitus (GDM): 
 A temporary metabolic disorder that any previously nondiabetic woman can develop during 
pregnancy, usually the third trimester. Hormonal changes contribute to this disease, along with 
excess weight and family history of diabetes. About 4% of pregnant women develop gestational 
diabetes, according to the American Diabetes Association. [15, 16] 
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Figure 2:- Blood Sugar Levels 
 
The type of diabetes is based on the presumed etiology. This table provides information about 
the two most common types of diabetes: type 1 and type 2 diabetes (Table 3). [19, 20] 
 
  
Type 1 
 
Type 2 
Age Childhood Pubertal 
Onset Acute; severe Mild-severe; often insidious 
Insulin secretion Very low Variable 
Insulin sensitivity Normal Decreased 
Insulin dependence Permanent Temporary; may occur later 
Racial/ethnic groups at increased 
risk 
All (low in Asians) 
 
African Americans, Hispanics, Native 
Americans, Asian/Pacific Islanders 
Genetics Polygenic Polygenic 
Proportion of those with diabetes 80% 10%-20% 
Association: obesity No Strong 
Acanthosis nigricans No Yes 
Autoimmune etiology Yes No 
 
Table 3:- Characteristic features of Type 1 and Type 2 Diabetes 
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INSULIN BIOSYNTHESIS, SECRETION, AND ACTION [21] 
 
Biosynthesis 
 
Insulin is produced in the beta cells of the pancreatic islets. It is initially synthesized as a single 
chain 86-amino-acid precursor polypeptide, preproinsulin. Subsequent proteolytic processing 
removes the aminoterminal signal peptide, giving rise to proinsulin. Proinsulin is structurally 
related to insulin-like growth factors I and II, which bind weakly to the insulin receptor. Cleavage 
of an internal 31-residue fragment from proinsulin generates the C peptide and the A (21 amino 
acids) and B (30 amino acids) chains of insulin, which are connected by disulfide bonds. The 
mature insulin molecule and C peptide are stored together and co-secreted from secretory granules 
in the beta cells. Because C peptide is cleared more slowly than insulin, it is a useful marker of 
insulin secretion and allows discrimination of endogenous and exogenous sources of insulin in the 
evaluation of hypoglycemia. Pancreatic beta cells co-secrete islet amyloid polypeptide (IAPP) or 
amylin, a 37-amino-acid peptide, along with insulin. The role of IAPP in normal physiology is 
incompletely defined, but it is the major component of the amyloid fibrils found in the islets of 
patients with type 2 diabetes, and an analogue is sometimes used in treating type 1 and type 2 DM. 
Human insulin is produced by recombinant DNA technology; structural alterations at one or more 
amino acid residues modify its physical and pharmacologic characteristics. 
 
Secretion 
 
Glucose is the key regulator of insulin secretion by the pancreatic beta cell, although amino acids, 
ketones, various nutrients, gastrointestinal peptides, and neurotransmitters also influence insulin 
secretion. Glucose levels >3.9 mmol/L (70 mg/dL) stimulate insulin synthesis, primarily by 
enhancing protein translation and processing. Glucose stimulation of insulin secretion begins with 
its transport into the beta cell by a facilitative glucose transporter (Fig. 3). Glucose phosphorylation 
by glucokinase is the rate-limiting step that controls glucose-regulated insulin secretion. Further 
metabolism of glucose-6-phosphate via glycolysis generates ATP, which inhibits the activity of an 
ATP-sensitive K+ channel. This channel consists of two separate proteins: one is the binding site 
for certain oral hypoglycemics (e.g., sulfonyl-ureas, meglitinides); the other is an inwardly 
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rectifying K+ channel protein (Kir6.2). Inhibition of this K+ channel induces beta cell membrane 
depolarization, which opens voltage-dependent calcium channels (leading to an influx of calcium), 
and stimulates insulin secretion. Insulin secretory profiles reveal a pulsatile pattern of hormone 
release, with small secretory bursts occurring about every 10 min, superimposed upon greater 
amplitude oscillations of about 80–150 min. Incretins are released from neuroendocrine cells of 
the gastrointestinal tract following food ingestion and amplify glucose stimulated insulin secretion 
and suppress glucagon secretion. Glucagon-like peptide 1 (GLP-1), the most potent incretin, is 
released from L cells in the small intestine and stimulates insulin secretion only when the blood 
glucose is above the fasting level. Incretin analogues, are used to enhance endogenous insulin 
secretion. 
 
 
 
 
Figure 3:- Mechanisms of glucose-stimulated insulin secretion and abnormalities in diabetes 
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Action 
 
Once insulin is secreted into the portal venous system, 50% is removed and degraded by the liver. 
Unextracted insulin enters the systemic circulation where it binds to receptors in target sites. 
Insulin binding to its receptor stimulates intrinsic tyrosine kinase activity, leading to receptor 
autophosphorylation and the recruitment of intracellular signaling molecules, such as insulin 
receptor substrates (IRS) (Fig. 4). IRS and other adaptor proteins initiate a complex cascade of 
phosphorylation and dephosphorylation reactions, resulting in the widespread metabolic and 
mitogenic effects of insulin. As an example, activation of the phosphatidylinositol-3′-kinase (PI-
3-kinase) pathway stimulates translocation of a facilitative glucose transporter (e.g., GLUT4) to 
the cell surface, an event that is crucial for glucose uptake by skeletal muscle and fat. Activation 
of other insulin receptor signaling pathways induces glycogen synthesis, protein synthesis, 
lipogenesis, and regulation of various genes in insulin-responsive cells. 
 
 
 
 
Figure 4 Insulin signal transduction pathway in skeletal muscle 
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Glucose homeostasis reflects a balance between hepatic glucose production and peripheral glucose 
uptake and utilization. Insulin is the most important regulator of this metabolic equilibrium, but 
neural input, metabolic signals, and other hormones (e.g., glucagon) result in integrated control of 
glucose supply and utilization. In the fasting state, low insulin levels increase glucose production 
by promoting hepatic gluconeogenesis and glycogenolysis and reduce glucose uptake in insulin-
sensitive tissues (skeletal muscle and fat), thereby promoting mobilization of stored precursors 
such as amino acids and free fatty acids (lipolysis). Glucagon, secreted by pancreatic alpha cells 
when blood glucose or insulin levels are low, stimulates glycogenolysis and gluconeogenesis by 
the liver and renal medulla. Postprandially, the glucose load elicits a rise in insulin and fall in 
glucagon, leading to a reversal of these processes. Insulin, an anabolic hormone, promotes the 
storage of carbohydrate and fat and protein synthesis. The major portion of postprandial glucose 
is utilized by skeletal muscle, an effect of insulin-stimulated glucose uptake. Other tissues, most 
notably the brain, utilize glucose in an insulin-independent fashion. [21] 
 
PATHOGENESIS AND PATHOPHYSIOLOGY OF DIABETES MELLITUS 
 
There is a direct link between hyperglycemia and physiological & behavioral responses. Whenever 
there is hyperglycemia, the brain recognizes it and send a message through nerve impulses to 
pancreas and other organs to decrease its effect [22]. 
 
Figure 5:- Normal and Type of Diabetes 
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PATHOGENESIS OF TYPE 1 DIABETES MELLITUS (IDDM) 
 
Type 1 diabetes mellitus is a chronic autoimmune disease associated with selective destruction of 
insulin-producing pancreatic β-cells (Figure 5) by CD4+ and CD8+ T cells and macrophages 
infiltrating the islets. The onset of clinical disease represents the end stage of β-cell destruction 
leading to type 1 diabetes mellitus. Several features characterize type 1 diabetes mellitus as an 
autoimmune disease [24, 25]. 
1. Presence of immuno-competent and accessory cells in infiltrated pancreatic islets; 
 
2. Association of susceptibility to disease with the class II (immune response) genes of the 
major histocompatibility complex (MHC; human leucocyte antigens HLA); 
 
3. Presence of islet cell specific autoantibodies; 
 
4. Alterations of T cell mediated immunoregulation, in particular in CD4+ T cell 
compartment; 
 
5. The involvement of monokines and TH1 cells producing interleukins in the disease 
process; 
 
6. Response to immunotherapy and; 
 
7. Frequent occurrence of other organ specific auto- immune diseases in affected individuals  
Or in their family members. 
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Figure 6:- pathogenesis of type 1 diabetes mellitus 
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PATHOPHYSIOLOGY TYPE 1 DIABETES MELLITUS (IDDM) 
Approximately 85% of patients have circulating islet cell antibodies, and the majorities also have 
detectable anti-insulin antibodies before receiving insulin therapy. Most islet cell antibodies are 
directed against glutamic acid decarboxylase (GAD) within pancreatic B cells [26]. 
The autoimmune destruction of pancreatic β-cells, leads to a deficiency of insulin secretion which 
results in the metabolic derangements associated with T1DM. In addition to the loss of insulin 
secretion, the function of pancreatic α-cells is also abnormal and there is excessive secretion of 
glucagon in T1DM patients. Normally, hyperglycemia leads to reduced glucagon secretion, 
however, in patients with T1DM, glucagon secretion is not suppressed by hyperglycemia [26, 27]. 
The resultant inappropriately elevated glucagon levels exacerbate the metabolic defects due to 
insulin deficiency. Although insulin deficiency is the primary defect in T1DM, there is also a 
defect in the administration of insulin. Deficiency in insulin leads to uncontrolled lipolysis and 
elevated levels of free fatty acids in the plasma, which suppresses glucose metabolism in peripheral 
tissues such as skeletal muscle [27]. This impairs glucose utilization and insulin deficiency also 
decreases the expression of a number of genes necessary for target tissues to respond normally to 
insulin such as glucokinase in liver and the GLUT 4 class of glucose transporters in adipose tissue 
[34] explained that the major metabolic derangements, which result from insulin deficiency in 
T1DM are impaired glucose, lipid and protein metabolism. [13] 
 
Effects on glucose metabolism  
Uncontrolled IDDM leads to increased hepatic glucose output. First, liver glycogen stores are 
mobilized then hepatic gluconeogenesis is used to produce glucose. Insulin deficiency also impairs 
non hepatic tissue utilization of glucose. In particular in adipose tissue and skeletal muscle, insulin 
stimulates glucose uptake. This is accomplished by insulin mediated movement of glucose 
transporters proteins to the plasma membrane of these tissues. Reduced glucose uptake by 
peripheral tissues in turn leads to a reduced rate of glucose metabolism. In addition, the level of 
hepatic glucokinase is regulated by insulin. Therefore, a reduced rate of glucose phosphorylation 
in hepatocytes leads to increased delivery to the blood. Other enzymes involved in anabolic 
metabolic metabolism of glucose are affected by insulin.  
The combination of increased hepatic glucose production and reduced peripheral tissues 
metabolism leads to elevated plasma glucose levels. When the capacity of the kidneys to absorb 
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glucose is suppressed, glucosuria ensues. Glucose is an osmotic diuretic and an increase in renal 
loss of glucose is accompanied by loss of water and electrolyte. The result of the loss of water (and 
overall volume) leads to the activation of the thirst mechanism (polydipsia). The negative caloric 
balance, which results from the glucosuria and tissue catabolism leads to an increase in appetite 
and food intake that is polyphagia [26]. 
 
 
Figure 7:- glucose metabolism 
 
Effect on lipid metabolism  
One major role of insulin is to stimulate the storage of food energy in the form of glycogen in 
hepatocytes and skeletal muscle, following the consumption of a meal. In addition, insulin 
stimulates hepatocytes to synthesize and store triglycerides in adipose tissue. In uncontrolled 
IDDM there is a rapid mobilization of triglycerides leading to increased levels of plasma free fatty 
acids. The free fatty acids are taken up by numerous tissue (except the brain) and metabolized to 
provide energy. In the absence of insulin, malonyl CoA levels fall, and transport of fatty acyl-CoA 
into the mitochondria increases. Mitochondrial oxidation of fatty acids generates acetyl CoA that 
can be further oxidized in the TCA cycle. However, in hepatocytes the majority of the acetyl CoA 
is not oxidized by the TCA cycle but is metabolized into the ketone bodies (acetoacetate and B-
hydroxybutyrate). These ketone bodies are used for energy production by the brain, heart and 
skeletal muscle. In IDDM, the increased availability of free fatty acids and ketone bodies 
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exacerbates the reduced utilization of glucose, furthering the ensuing hyperglycemia. Production 
of ketone bodies in excess of the body’s ability to utilize them leads to ketoacidosis. A spontaneous 
breakdown product of acetoacetate is the acetone that is exhaled by the lungs, which gives a 
distinctive odor to the breath. Normally, plasma triglycerides are acted upon by lipoprotein lipase 
(LPL) that requires insulin. LPL is a membrane bound enzyme on the surface of the endothelial 
cells lining the vessels, which allows fatty acids to be taken from circulating triglycerides for 
storage in adipocytes [26]. The absence of insulin results in hypertriglyceridemia.  
 
Effects on protein  
Insulin regulates the synthesis of many genes, either positively or negatively, which affect overall 
metabolism. Insulin has an overall effect on protein metabolism, increasing the rate of protein 
synthesis and decreasing the rate of protein degradation. Thus insulin deficiency will lead to 
increased catabolism of protein. The increased rate of proteolysis leads to elevated concentration 
of amino acids in plasma [26].Glucogenic amino acids serve as precursors for hepatic and renal 
glyconeogenesis, which further contributes to the hyperglycemia seen in IDDM  
 
IMMUNOLOGIC MARKERS 
Islet cell autoantibodies (ICAs) are a composite of several different antibodies directed at 
pancreatic islet molecules such as GAD, insulin, IA-2/ICA-512, and ZnT-8, and serve as a marker 
of the autoimmune process of type 1 DM. Assays for autoantibodies to GAD-65 are commercially 
available. Testing for ICAs can be useful in classifying the type of DM as type 1 and in identifying 
non-diabetic individuals at risk for developing type 1 DM. ICAs are present in the majority of 
individuals (>85%) diagnosed with new-onset type 1 DM, in a significant minority of individuals 
with newly diagnosed type 2 DM (5–10%), and occasionally in individuals with GDM (<5%). 
ICAs are present in 3–4% of first degree relatives of individuals with type 1 DM. In combination 
with impaired insulin secretion after IV glucose tolerance testing, they predict a >50% risk of 
developing type 1 DM within 5 years. At present, the measurement of ICAs in non-diabetic 
individuals is a research tool because no treatments have been approved to prevent the occurrence 
or progression to type 1 DM. Clinical trials are testing interventions to slow the autoimmune beta 
cell destruction.[28] 
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ENVIRONMENTAL FACTORS 
Numerous environmental events have been proposed to trigger the autoimmune process in 
genetically susceptible individuals; however, none have been conclusively linked to diabetes. 
Identification of an environmental trigger has been difficult because the event may precede the 
onset of DM by several years. Putative environmental triggers include viruses (coxsackie, rubella, 
enteroviruses most prominently), bovine milk proteins, and nitrosourea compounds. [28] 
 
PREVENTION OF TYPE 1 DM 
A number of interventions have successfully delayed or prevented diabetes in animal models. 
Some interventions have targeted the immune system directly (immunosuppression, selective T-
cell subset deletion, induction of immunologic tolerance to islet proteins), whereas others have 
prevented islet cell death by blocking cytotoxic cytokines or increasing islet resistance to the 
destructive process. Though results in animal models are promising, these interventions have not 
been successful in preventing type 1 DM in humans. 
The Diabetes Prevention Trial--type 1 concluded that administering insulin (IV or PO) to 
individuals at high risk for developing type 1 DM did not prevent type 1 DM. In patients with new-
onset type 1 diabetes, treatment with anti-CD3 monoclonal antibodies, a GAD vaccine, and anti-
B lymphocyte monoclonal antibody have been shown to slow the decline in C-peptide levels. This 
is an area of active clinical investigation. [28] 
 
Clinical Manifestations 
 
 Polyuria       : increased frequency of urination, and particularly urination at night 
(nocturia). 
 Polydipsia    : increased thirst. 
 Polyphagia   : increased hunger. 
 Fatigue or lethargy. 
 Weight loss. 
 Recurrent infections like urinary tract infection or skin infection. 
 Symptoms of ketoacidosis which include drowsiness, rapid breathing, dehydration, 
abdominal pain, nausea and vomiting, decreased consciousness or coma.[a] 
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                        Figure 8:- main symptoms of diabetes mellitus 
 
PATHOGENESIS TYPE 2 DIABETES MELLITUS (NIDDM) 
 
Under normal physiological conditions, plasma glucose concentrations are maintained within a 
narrow range, despite wide fluctuations in supply and demand, through a tightly regulated and 
dynamic interaction between tissue sensitivity to insulin (especially in liver) and insulin secretion 
[29]. Two main pathological defects in type 2 diabetes are impaired insulin secretion through a 
dysfunction of the pancreatic β-cell, and impaired insulin action through insulin resistance [30]. 
Type 2 diabetes mellitus has a greater genetic association than type 1 DM, the pathogenesis of type 
2 diabetes mellitus is characterized by impaired insulin secretion and insulin resistance as shown 
in Fig 9 [31]. 
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Insulin resistance 
 
The primary events are believed to be an initial deficit in insulin secretion and in many patients 
relative insulin deficiency in association with peripheral insulin resistance [34]. Resistance to the 
action of insulin will result in impaired insulin mediated glucose uptake in the periphery (by 
muscle and fat), incomplete suppression of hepatic glucose output and impaired triglyceride uptake 
by fat. To overcome the insulin resistance, islet cells will increase the amount of insulin secreted. 
Endogenous glucose production is accelerated in patients with type 2 diabetes or impaired fasting 
glucose. Because this increase occurs in the presence of hyper insulinemia, at least in the early and 
intermediate disease stages, hepatic insulin resistance is the driving force of hyperglycemia of type 
2 diabetes 
Insulin resistance and hyperinsulinemia eventually lead to impaired glucose tolerance [32]. Except 
for maturity onset diabetes of the young (MODY), the mode of inheritance for type 2 diabetes 
mellitus is unclear. MODY, inherited as an autosomal dominant trait, may result from mutations 
in glucokinase gene on chromosome 7p. MODY is defined as hyperglycemia diagnosed before the 
age of twenty-five years and treatable for over five years without insulin in cases where islet cell 
antibodies (ICA) are negative [33]. 
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Figure 9:-Pathogenesis of type 2 diabetes characterized by impaired insulin secretion and insulin 
resistance 
 
 
 
PATHOPHYSIOLOGY OF TYPE 2 DIABETES (NIDDM) 
Individuals with NIDDM have detectable levels of circulating insulin, unlike patients with 
IDDM.the pathophysiology of type 2 diabetes is described in Fig 10. [35] 
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Figure 10:-Pathophysiology of type 2 diabetes mellitus. 
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Type 2 DM is characterized by impaired insulin secretion, insulin resistance, excessive hepatic 
glucose production, and abnormal fat metabolism. Obesity, particularly visceral or central (as 
evidenced by the hip-waist ratio), is very common in type 2 DM (80% or more are obese). In the 
early stages of the disorder, glucose tolerance remains near-normal, despite insulin resistance, 
because the pancreatic beta cells compensate by increasing insulin output (Fig. 11). As insulin 
resistance and compensatory hyperinsulinemia progress, the pancreatic islets in certain individuals 
are unable to sustain the hyperinsulinemic state. Impaired Glucose Tolerance, characterized by 
elevations in postprandial glucose, then develops. A further decline in insulin secretion and an 
increase in hepatic glucose production lead to overt diabetes with fasting hyperglycemia. 
Ultimately, beta cell failure ensues. 
 
 
 
Figure 11:-Metabolic changes during the development of type 2 diabetes mellitus (DM) 
 
 Insulin secretion and insulin sensitivity are related, and as an individual becomes more insulin 
resistant (by moving from point A to point B), insulin secretion increases. A failure to compensate 
by increasing the insulin secretion results initially in impaired glucose tolerance (IGT; point C) 
and ultimately in type 2 DM (point D). [36] 
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METABOLIC ABNORMALITIES 
 
Abnormal Muscle and Fat Metabolism 
 
Insulin resistance, the decreased ability of insulin to act effectively on target tissues (especially 
muscle, liver, and fat), is a prominent feature of type 2 DM and results from a combination of 
genetic susceptibility and obesity.  Insulin resistance impairs glucose utilization by insulin-
sensitive tissues and increases hepatic glucose output; both effects contribute to the hyperglycemia. 
Increased hepatic glucose output predominantly accounts for increased FPG levels, whereas 
decreased peripheral glucose usage results in postprandial hyperglycemia. In skeletal muscle, there 
is a greater impairment in non-oxidative glucose usage (glycogen formation) than in oxidative 
glucose metabolism through glycolysis. Glucose metabolism in insulin-independent tissues is not 
altered in type 2 DM. The precise molecular mechanism leading to insulin resistance in type 2 DM 
has not been elucidated. Insulin receptor levels and tyrosine kinase activity in skeletal muscle are 
reduced, but these alterations are most likely secondary to hyperinsulinemia and are not a primary 
defect. Therefore, "post receptor" defects in insulin-regulated phosphorylation/de-phosphorylation 
appear to play the predominant role in insulin resistance (Fig.5). For example, a PI-3-kinase 
signaling defect might reduce translocation of GLUT4 to the plasma membrane. Other 
abnormalities include the accumulation of lipid within skeletal myocytes, which may impair 
mitochondrial oxidative phosphorylation and reduce insulin-stimulated mitochondrial ATP 
production. Impaired fatty acid oxidation and lipid accumulation within skeletal myocytes also 
may generate reactive oxygen species such as lipid peroxides. Of note, not all insulin signal 
transduction pathways are resistant to the effects of insulin (e.g., those controlling cell growth and 
differentiation using the mitogenic-activated protein kinase pathway). Consequently, 
hyperinsulinemia may increase the insulin action through these pathways, potentially accelerating 
diabetes-related conditions such as atherosclerosis. The obesity accompanying type 2 DM, 
particularly in a central or visceral location, is thought to be part of the pathogenic process. The 
increased adipocyte mass leads to increased levels of circulating free fatty acids and other fat cell 
products. The increased production of free fatty acids and some adipokines may cause insulin 
resistance in skeletal muscle and liver. For example, free fatty acids impair glucose utilization in 
skeletal muscle, promote glucose production by the liver, and impair beta cell function. In contrast, 
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the production by adipocytes of adiponectin, an insulin-sensitizing peptide, is reduced in obesity, 
and this may contribute to hepatic insulin resistance. Adipocyte products and adipokines also 
produce an inflammatory state and may explain why markers of inflammation such as IL-6 and C-
reactive protein are often elevated in type 2 DM. In addition, inflammatory cells have been found 
infiltrating adipose tissue. Inhibition of inflammatory signaling pathways such as the nuclear factor 
B (NF- B) pathway appears to reduce insulin resistance and improve hyperglycemia in animal 
models. [28] 
  
IMPAIRED INSULIN SECRETION 
Insulin secretion and sensitivity are interrelated (Fig. 11). In type 2 DM, insulin secretion initially 
increases in response to insulin resistance to maintain normal glucose tolerance. Initially, the 
insulin secretory defect is mild and selectively involves glucose-stimulated insulin secretion. The 
response to other non-glucose secretagogues, such as arginine, is preserved. Abnormalities in 
proinsulin processing is reflected by increased secretion of proinsulin in type 2 diabetes. 
Eventually, the insulin secretory defect progresses to a state of inadequate insulin secretion. The 
reason(s) for the decline in insulin secretory capacity in type 2 DM is unclear. The assumption is 
that a second genetic defect—superimposed upon insulin resistance—leads to beta cell failure. 
Beta cell mass is decreased by approximately 50% in individuals with long-standing type 2 
diabetes. Islet amyloid polypeptide or amylin is co-secreted by the beta cell and forms the amyloid 
fibrillar deposit found in the islets of individuals with long-standing type 2 DM. Whether such islet 
amyloid deposits are a primary or secondary event is not known. The metabolic environment of 
diabetes may also negatively impact islet function. For example, chronic hyperglycemia 
paradoxically impairs islet function ("glucose toxicity") and leads to a worsening of 
hyperglycemia. Improvement in glycemic control is often associated with improved islet function. 
In addition, elevation of free fatty acid levels ("lipotoxicity") and dietary fat may also worsen islet 
function. [28] 
 
INCREASED HEPATIC GLUCOSE AND LIPID PRODUCTION 
In type 2 DM, insulin resistance in the liver reflects the failure of hyperinsulinemia to suppress 
gluconeogenesis, which results in fasting hyperglycemia and decreased glycogen storage by the 
liver in the postprandial state. Increased hepatic glucose production occurs early in the course of 
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diabetes, though likely after the onset of insulin secretory abnormalities and insulin resistance in 
skeletal muscle. As a result of insulin resistance in adipose tissue, lipolysis and free fatty acid flux 
from adipocytes are increased, leading to increased lipid [very low density lipoprotein (VLDL) 
and triglyceride] synthesis in hepatocytes. This lipid storage or steatosis in the liver may lead to 
nonalcoholic fatty liver disease and abnormal liver function tests. This is also responsible for the 
dyslipidemia found in type 2 DM [elevated triglycerides, reduced high-density lipoprotein (HDL), 
and increased small dense low-density lipoprotein (LDL) particles].[28] 
 
INSULIN RESISTANCE SYNDROMES 
 
The insulin resistance condition comprises a spectrum of disorders, with hyperglycemia 
representing one of the most readily diagnosed features. The metabolic syndrome, the insulin 
resistance syndrome, or syndrome X are terms used to describe a constellation of metabolic 
derangements that includes insulin resistance, hypertension, dyslipidemia (decreased HDL and 
elevated triglycerides), central or visceral obesity, type 2 diabetes or IGT/IFG, and accelerated 
cardiovascular disease. 
A number of relatively rare forms of severe insulin resistance include features of type 2 DM or 
IGT (Table 2). Mutations in the insulin receptor that interfere with binding or signal transduction 
are a rare cause of insulin resistance. Acanthosis nigricans and signs of hyperandrogenism 
(hirsutism, acne, and oligomenorrhea in women) are also common physical features. 
Two distinct syndromes of severe insulin resistance have been described in adults: 
 Type A, which affects young women and is characterized by severe hyperinsulinemia, 
obesity, and features of hyperandrogenism; and 
 Type B, which affects middle-aged women and is characterized by severe 
hyperinsulinemia, features of hyperandrogenism, and autoimmune disorders. 
 
Individuals with the type A insulin resistance syndrome have an undefined defect in the insulin-
signaling pathway; individuals with the type B insulin resistance syndrome have autoantibodies 
directed at the insulin receptor. These receptor autoantibodies may block insulin binding or may 
stimulate the insulin receptor, leading to intermittent hypoglycemia. Polycystic ovary syndrome 
(PCOS) is a common disorder that affects premenopausal women and is characterized by chronic 
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anovulation and hyperandrogenism. Insulin resistance is seen in a significant subset of women 
with PCOS, and the disorder substantially increases the risk for type 2 DM, independent of the 
effects of obesity. [28] 
 
RISK FACTORS: [37] 
 Obesity 
 Age (onset of puberty is associated with increased insulin resistance) 
 Lack of physical activity 
 Genetic predisposition 
 Racial/ethnic background (African American, Native American, Hispanic and 
Asian/Pacific Islander) 
 Conditions associated with insulin resistance, (e.g., polycystic ovary syndrome). 
 Family history of T2DM in first- or second-degree relative[38,13] 
 High-calorie diet 
 
COMPLICATIONS OF DIABETES MELLITUS [13] 
 
I. Acute complications 
 Hypoglycemia 
 Hyperglycemic crises 
a. Diabetes Ketoacidosis (DKA) 
b. Hyperglycemic hyperosmolar state (HHS) 
 
II. Chronic complications: 
 Micro vascular complications 
a. Diabetic retinopathy 
b. Diabetic nephropathy 
c. Diabetic neuropathy 
 Macro vascular disease 
                 3 Other complications and associated conditions 
 Impaired growth and development 
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 Associated autoimmune conditions 
a. Hypothyroidism 
b. Hyperthyroidism 
c. Celiac disease 
d. Vitiligo 
e. Primary adrenal insufficiency (Addison’s disease) 
 Lipodystrophy (lipoatrophy and lipohypertrophy) 
 Necrobiosis lipoidica diabeticorum 
 Non-alcoholic fatty liver disease 
 Infections seen in patients with diabetes 
 Limited joint mobility 
 Edema 
 
 
Diabetes Ketoacidosis (DKA) 
DKA results from relative or absolute insulin deficiency combined with counter regulatory 
hormone excess (glucagon, catecholamine, cortisol, and growth hormone). Both insulin deficiency 
and glucagon excess, in particular, are necessary for DKA to develop. The decreased ratio of 
insulin to glucagon promotes gluconeogenesis, glycogenolysis, and ketone body formation in the 
liver, as well as increases in substrate delivery from fat and muscle (free fatty acids, amino acids) 
to the liver.  
Nausea and vomiting, abdominal pain which resemble acute pancreatitis or ruptured viscus, 
Kussmaul respirations and a fruity odor on the patient's breath (secondary to metabolic acidosis 
and increased acetone) are classic signs of the disorder. [39] 
 
Hyperglycemic hyperosmolar state (HHS) 
The prototypical patient with HHS is an elderly individual with type 2 DM, with a several-week 
history of polyuria, weight loss, and diminished oral intake that culminates in mental confusion, 
lethargy, or coma. The physical examination reflects profound dehydration and hyper osmolality 
and reveals hypotension, tachycardia, and altered mental status. Notably absent are symptoms of 
nausea, vomiting, and abdominal pain and the Kussmaul respirations characteristic of DKA. [39] 
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Chronic Complications 
The chronic complications of DM affect many organ systems and are responsible for the majority 
of morbidity and mortality associated with the disease. Chronic complications can be divided into 
vascular and nonvascular complications. 
The vascular complications of DM are further subdivided into micro vascular (retinopathy, 
neuropathy, and nephropathy) and macro vascular complications [coronary heart disease (CHD), 
peripheral arterial disease (PAD), cerebrovascular disease].  
Nonvascular complications include problems such as gastroparesis, infections, and skin 
changes. Long-standing diabetes may be associated with hearing loss. [40] 
 
Diabetic retinopathy 
DM is the leading cause of blindness. Blindness is primarily the result of progressive diabetic 
retinopathy and clinically significant macular edema. Diabetic retinopathy is classified into two 
stages: non proliferative and proliferative. 
Non proliferative diabetic retinopathy usually appears late in the first decade or early in the 
second decade of the disease and is marked by retinal vascular micro aneurysms, blot hemorrhages, 
and cotton-wool spots. Mild non proliferative retinopathy progresses to more extensive disease, 
characterized by changes in venous vessel caliber, intraretinal micro vascular abnormalities, and 
more numerous microaneurysms and hemorrhages. [40] 
 
Necrobiosis lipoidica diabeticorum  
It is a rare disorder of DM that predominantly affects young women with type 1 DM, neuropathy, 
and retinopathy. It usually begins in the pretibial region as an erythematous plaque or papules that 
gradually enlarge, darken, and develop irregular margins, with atrophic centers and central 
ulceration. They may be painful. [40] 
 
Lipoatrophy and lipohypertrophy 
It occur at insulin injection sites but are now unusual with the use of human insulin. Xerosis and 
pruritus are common and are relieved by skin moisturizers. [40] 
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DIAGNOSIS OF DIABETES MELLITUS  
 
Random plasma test 
• The simplest test and doesn’t require fasting before taking the test. 
• If 200 or more than 200 mg/dl of blood glucose it probably indicates diabetes but has to be 
reconfirmed. 
 
Fasting plasma glucose test: 
• There should be eight hours fasting before taking this test. Blood glucose more than 126 mg/dl 
on two or more tests conducted on different days confirms a diabetes diagnosis [41]. 
 
Oral glucose tolerance test 
• When random plasma glucose test is 160-200 mg/dl and the fasting plasma test is 110-125 mg/dl, 
then this test is conducted [42]. 
• This blood test evaluates body’s response to glucose. This test requires fasting at least eight but 
not more than 16 hrs. 
• Fasting glucose level is determined, and then gives 75 gm of glucose, 100 gm for pregnant 
women. The blood is tested every 30 minutes to one hr for two or three hrs. 
• This test is normal if your glucose level at two hrs is less than 140 mg/dl. A fasting level of 126 
mg/dl or greater and two hour glucose level of 200 mg/dl or higher confirms a diabetes diagnosis 
[41]. 
 
MANAGEMENT OF DIABETICS MELLITUS 
Treatment for Type 1 Diabetes 
 
Insulin Therapy 
Insulin is lifesaving pharmacological therapy for people with type 1 diabetes. Insulin preparations 
are primarily produced by recombinant DNA technology and are formulated either as structurally 
identical to human insulin or as a modification of human insulin (insulin analogues) to alter 
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pharmacokinetics. Human insulin and insulin analogues are preferred and used by most adults with 
type 1 diabetes [43] 
Insulin is the only medication that is effective in lowering blood glucose levels in type 1 diabetes. 
The use of insulin requires daily management of those factors that affect the insulin dose (food, 
physical activity, illness, stress). Rapid-acting insulin may be given before, during, or immediately 
after a meal. Administration after a meal may help reduce the postprandial hyperglycemia 
associated with high fat meals. The number of insulin injections/day will vary; insulin may be 
delivered with insulin syringes, insulin pens or external insulin pumps. [37] 
 
Insulin preparations are classified according to their duration of action and are further 
differentiated by their time of onset and peak actions. Premixed insulin preparations are available 
and are not generally suitable for intensive treatment in patients with type 1 diabetes in whom 
frequent adjustments of insulin are required. [43] 
 
Types of Insulin [44] 
 
Insulin 
Preparation 
Name Onset Peak 
 
Duration 
 
Rapid-acting 
insulin 
Analogues 
(Clear) 
Insulin aspart  
Insulin Lispro 
Insulin Glulisine  
 
 
5 to 15 minutes 
 
1 to 2 hours 
 
4 to 5 hours  
 
Short-acting 
Insulin (Clear) 
 
 
Humulin-Regular  
Or regular insulin 
 
20 to 60 
minutes 
 
2 to 4 hours  
 
8 to 10 hours 
 
Intermediate 
acting (Cloudy) 
 
 
Humulin-NPH or  
NPH 
 
1 to 2 hours 
 
4 to 8 hours  
 
10 to 20 hours 
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Long-acting 
Insulin 
analogues 
(Clear) 
 
Insulin detemir  
 
 
Insulin glargine 
 
1 to 2 hours 
 
 
1 to 2 hours 
 
Relatively flat 
 
Relatively flat 
  
12 to 20 hours 
 
20 to 24 hours  
 
Pre-Mixed 
insulin 
Multiple 
preparations 
 
 
 
 
 
 
 
 
NPH/Regular mix 
PreMix 70/30 (NPH/Regular) 
(Premix Regular) 
 
NPH/Rapid Acting Insulin mix 
NPH/ Aspart 
PreMix Novolog 70/30 
 
NPH/Lispro 
 
PreMix Humalog 75/25 
(Premix Rapid acting) 
 
 
 
A single vial or cartridge 
contains a fixed ratio of insulin 
(% of rapid-acting or short-
acting insulin to % of 
intermediate- acting insulin) 
 
 
Table 4:- Insulin Preparations 
 
Treatment for Type 2 Diabetes 
 
General Aspects 
 
The goals of therapy for type 2 DM are similar to those in type 1. While glycemic control tends to 
dominate the management type 2 DM must also include attention to the treatment of conditions 
associated with type 2 DM (obesity, hypertension, detection/management of DM-related 
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complications. DM-specific complications may be present in up to type 2 DM. Reduction in 
cardiovascular risk is of paramount importance as this is the leading cause of mortality in these 
and lipid goals should begin in concert with glucose-lowering interventions.[45] 
 
 
 
Figure 12:- Management of Type 2 Diabetes 
CLASSES OF ORAL HYPOGLYCEMIC AGENTS[b] 
Drug class Agent 
 
 
 
 Sulfonylureas 
First generation 
             Acetohexamide 
             Chlorpropamide 
             Tolazamide 
             Tolbutamide 
Second generation 
                Glyburide 
             Glipizide 
             Glimepiride 
 Meglitinides 
 
             Repaglinide  
             Nateglinide 
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 Biguanides 
 
Metformin 
 
 Thiazolidinediones 
Pioglitazone  
Rosiglitazone 
 
 Alpha-glucosidase inhibitors 
Acarbose  
Miglitol 
 
 GLP-1 agonist 
Exenatide 
Liraglutide 
 
 Dipeptidyl Peptidase-4 
Inhibitors 
Saxagliptin  
Sitagliptin 
Vildagliptin[45] 
 
Table:-5 oral hypoglycemic agents 
 
Figure:-13 site of action of diabetic drugs 
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 MODELS FOR EXPERIMENTAL DIABETES MELLITUS 
 
The various animal models for inducing diabetes are:  
 
I. Chemical induction of diabetes mellitus: 
a. Streptozotocin induced diabetes 
b. Alloxan induced diabetes  
c. Ferric nitrilotriacetate induction of diabetes mellitus 
d. Other diabetogenic compounds  
II. Surgical model of diabetes mellitus 
a. Pancreatectomy in dogs  
III. Genetic models of diabetes 
a. Spontaneously develop diabetic rats 
b. Genetically engineered diabetic mice 
IV. Hormone induced diabetes  
V. Insulin deficiency due to insulin antibodies  
VI. Virus induced diabetes [77,78] 
Streptozotocin Model of Diabetes Mellitus 
 
Streptozotocin or streptozocin or Izostazin or zanosar (STZ) is a synthetic nitrosoureido 
glucopyranose derivative isolated from fermentations of Streptomyces achromogenes that is 
classically an anti tumor antibiotic and chemically is related to other nitrosureas used in cancer 
chemotherapy. The chemical name of Streptozotocin is 2-Deoxy-2[(methylnitrosoamino)-
carbonyl] amino]-Dglucopyranose [78].It is a broad spectrum antibiotic and alkylating genotoxic 
agent which possesses antibacterial, tumoricidal, carcinogenic and diabetogenic properties. 
However, STZ is not a drug of choice for treatment of cancers due to development of resistance to 
its genotoxic effects. More specifically, STZ exhibits pancreatic beta-cell toxicity and is often used 
to induce diabetes in experimental animals [80] 
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How STZ Works 
 Streptozotocin enters the pancreatic β-cell via a glucose transporter-GLUT2 and causes 
alkylation of deoxyribonucleic acid(DNA)  
 The exact mechanism of targeted beta-cell toxicity is, however, not clear. STZ induces 
beta-cell dysfunction and apoptosis at lower doses while causing beta-cell necrosis at 
higher doses 
 Insulin-secretory cells also develop resistance on repeated exposures to STZ through a 
wide spectrum of toxin tolerance mechanisms 
 STZ induces oxidative stress by activation of poly adenosine diphosphate ribosylation and 
nitric oxide release. 
 As a result of STZ action, pancreatic β-cells are destroyed by necrosis[79,80] 
 
 
Single dose of STZ in sterile citrate buffer (e.g. pH 4.5 0.1M) may be used: mice 150 mg/kg; rats 
80 mg/kg, administered intraperitoneally [78].After the administration of streptozotocin, three 
phases of blood glucose changes are observed. Initially, blood glucose is increased, reaching 
values of 150–200 mg%. Then the serum insulin values are increased up to 4 times, resulting in a 
hypoglycemic phase which is followed by persistent hyperglycemia. Severity and onset of diabetic 
symptoms depend on the dose of streptozotocin. After the dose of 60 mg/kg i.v, symptoms occur 
already after 24–48 hours with hyperglycemia up to 800 mg%, glucosuria and ketonemia. 
Histologically, the beta-cells are degranulated or even necrotic. After that steady state is reached 
allowing the use the animals for pharmacological tests. [77] 
 
PROBLEMS ASSOCIATED WITH MODERN DRUG THERAPY [46, 47, 48, 49, 50] 
INSULIN THERAPY 
1. Hypoglycemia: Manifested by:- 
                         Coma due to blood glucose to the brain. 
                         Sympathetic: tachycardia, sweating, anxiety. 
                         Parasympathetic: Nausea, Vomiting 
2. Weight gain 
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3. Hypersensitivity reactions. 
4. Lipodystrophy at injection site 
5. Insulin resistance 
6. Hypokalemia 
 
SULFONYLUREAS 
1. Hyperinsulinemia & Hypoglycemia: 
                                   More in chlorpropamide & glibenclamide  
                                   Less in tolbutamide. 
                                   More in elderly and patients with renal disease. 
2. Weight gain due to increase in appetite 
3. GIT upset. 
4. Dilutional hyponatremia, water intoxication (Chlorpropamide) vasopressin effect. 
5. Disulfiram-like reaction with alcohol (chlorpropamide). 
6. Tachyphylaxis (secondary failure).  
Contraindications 
1. Pregnancy (use insulin) 
2. Hepatic or renal insufficiency 
3. Type I diabetes 
 
MEGLITINIDES 
1. less incidence than sulfonylureas 
2. Hypoglycemia (meal is delayed). 
3. Weight gain. 
4. Drug interactions. 
 
Contraindications 
1. Hepatic and renal impairment. 
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BIGUANIDES  
1. Metallic taste in the mouth 
2. GIT disturbances (nausea, vomiting, diarrhea). 
3. Lactic acidosis:  Common in patients with renal disease, liver, pulmonary or cardiac 
disease. 
4. Long term use interferes with B12absorption. 
 
Contraindications 
1. Pregnancy 
2. Renal disease.  
3. Liver disease. 
4. Alcoholism. 
5. Conditions predisposing to hypoxia as cardiopulmonary dysfunction. 
 
THIAZOLIDINEDIONES 
1. Fluid retention (Edema). 
2. Weight gain. 
3. Headache. 
4. Liver function tests for 1styear of therapy. 
5. Failure of estrogen-containing oral contraceptives 
Contraindications 
1. Heart failure. 
2. Pregnancy. 
3. Significant liver disease. 
α-GLUCOSIDASE INHIBITORS 
1. GIT: Flatulence, diarrhea, abdominal pain, bloating, increase in liver enzymes  
Contraindications 
1. Inflammatory bowel disorders (IBD). 
2. Renal disease. 
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3. Hepatic disease (used with caution). 
4. Intestinal obstruction 
 
DIPEPTIDYL PEPTIDASE-4 INHIBITOR (DPP-4 INHIBITORS) 
 
1. Nausea ,abdominal pain ,diarrhea 
2. Nasopharyngitis[46,47,48,49,50] 
  
ADVANTAGE OF THE USE OF HERBAL MEDICINE IN DIABETICS MELLITUS 
Herbal medicinal products are defined as any medicinal product, exclusively containing one or 
more active substances. Herbs had been used by all cultures throughout history. It was an integral 
part of the development of modern civilization. Herbal marketers globally increase due to safe 
drug delivery with fewer side effect compared to synthetic drugs. 
In the present scenario, the demand for herbal products is growing exponentially throughout the 
world and major pharmaceutical companies are currently conducting extensive research on plant 
materials for their potential medicinal value. In many journals, national and international, we find 
an increasing number of research publications based on herbal drugs. Many analysis‐based studies 
regarding pharmacological research in India have been conducted in the past [53, 54, 55]. 
 
HERBAL DRUGS 
“Herbal formulation mean a dosage form consisting of one or more herbs or processed herb(s) in 
specified quantities to provide specific nutritional, cosmetic benefits, and/or other benefits meant 
for use to diagnose treat, mitigate diseases of human beings or animals and/or to alter the structure 
or physiology of human beings or animals”. Herbal preparations are obtained by subjecting whole 
plant, fragmented or cut plants, plants parts to treatments such as extraction, distillation, 
expression, fractionation, purification, concentration or fermentation. These include comminuted 
or powdered herbal substances, tinctures, extracts, essential oils, expressed juices and processed 
exudates [51]. 
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 SCOPE OF STUDY 
As per ancient literature, more than 800 plants are reported to have antidiabetic properties 
[56]. Ethno pharmacological surveys indicate that more than 1200 plants are used in traditional 
medicine for their alleged hypoglycemic activity [57]. Medicinal plants, since times immemorial, 
have been used in virtually all cultures as a source of medicine. A study of ancient literature 
indicates that diabetes was fairly well known and well conceived as an entity in ancient India. The 
knowledge of the system of diabetes mellitus, as the history reveals, existed with the Indians since 
prehistoric age. Its earliest reference (1000 BC in the Ayurvedic literature) is found in 
mythological form where it is said to have originated by eating Havisha, [58] a special food, which 
used to be offered at the times of yagna organized by Dakshaprajapati. 
Ayurvedic antidiabetic herbs improve digestive power, increase one of the Rasas (gastric 
secretions); being Laghu, get easily digested in the body; and being Ruksha, decrease output of 
overall body fluids e.g. urine, sweat etc. Food items, which are ‘madhumehaghna’ (antidote), are 
an important underlying principle of therapy for the prameha (diabetes) patient. Food items which 
correct the metabolic imbalance by their action e.g. foods exhibiting ‘rasa’, ‘katu’, ‘laghu’, 
‘medaghna’, properties are old cereals, roasted cereals, barley, jawar, ragi, mung dal, horse gram, 
tur dal, drumstick leaves, bitter gourd, jamun, amla, fig, raw papaya, milk, meat of animals that 
live in dry region, etc. The indigenous diet may not be useful in lowering the blood sugar to the 
same extent as insulin and other hypoglycemic agents do. But it has some other influences, which 
may be useful for the management of the disease and its complications [59]. Indian materia medica 
has mentioned numerous dravyas, which have been reported effective in Madhumeha [60]. 
Plants-based products have been popular all over the world for the centuries. In diabetes, some 
herbal alternatives are proven to provide symptomatic relief and assist in the prevention of the 
secondary complications of the disease. Some herbs have also been proven to help in the 
regeneration of ß-cells and in overcoming resistance. In addition to maintaining normal blood 
sugar level, some herbs are also reported to possess antioxidant activity and cholesterol lowering 
action. The management of type 2 diabetes mellitus (NIDDM) is possible with the drugs that can 
lower the blood sugar level in one hand and restore the liver glycogen level on the other. In modern 
system of medicine, there is no drug, which is reported to possess both of these properties [61]. 
However, the hypoglycemic effect of some herbal extracts have been confirmed in human and 
animal models of type 2 diabetes and conventional drugs have been derived from the active 
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molecules of these medicinal plants. Metformin, a less toxic biguanides and potent oral glucose-
lowering agent, was developed from Galega officianalis and used to treat diabetes [62]. Out of 
dozens of oral medications for diabetes, only one medication (metformin) is approved for use in 
children and it has been originated from herbs [63]. 
 
 
Mechanism of Action of Herbal Anti-diabetics [64, 65, 66] 
The antidiabetic activity of herbs depends upon variety of mechanisms. The mechanism of action 
of herbal anti-diabetic may be 
a. α –amylase inhibition. 
b. Inhibition in renal glucose reabsorption. 
c. Stimulation of insulin secretion from beta cells of islets or/and inhibition of insulin 
degradative processes. 
d. Cortisol lowering activities. 
e. Insulin resistance reduction. 
f. Providing certain necessary elements like calcium, zinc, magnesium, manganese and 
copper for the β -cells. 
g. Regenerating and/or repairing pancreatic β cells. 
h. Increasing the size and number of cells in the islets of Langerhans. 
i. Stimulation of insulin secretion. 
j. Stimulation of glycogenesis and hepatic glycolysis. 
k. Inhibition of β -galactocidase and α–glucocidase. 
l. Protective effect on the destruction of the β cells. 
m. Improvement in digestion along with reduction in blood sugar and urea. 
n. Prevention of pathological conversion of starch to glucose. 
 
 
Advantages [52] 
 
1. Mostly herbal drugs are well tolerated by the patient, having fewer unintended consequences 
and fewer side effects than traditional medicine, and may be safer to use. 
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2. Herbal drugs are more effective for long-standing health complaints that don't respond well to 
traditional medicine. 
3. Cost of herbal drugs is much less than prescription medications. Research, testing, and 
marketing add considerably to the cost of prescription medicines. Herbs tend to be inexpensive 
compared to drugs. 
4. Herbs are available without a prescription. Simple herbs, such as peppermint and chamomile, 
can be cultivated at home. 
 
Limitations [52] 
 
1. An herbalist would not be able to treat serious trauma, such as a broken leg, nor would he be 
able to heal appendicitis or a heart attack as effectively as a conventional doctor using modern 
diagnostic tests, surgery, and drugs. 
2. Self treatment with herbal drugs may consist of many risk factors. Moreover with no proper 
direction of doses may lead to overdose. 
3. Consumption of herbal drugs without correct identification of plant i.e. use of wrong part of 
plant may lead to poisoning. 
4. All herbal drugs are not safe; some may be poisonous or may cause allergenic reactions. 
5. Curing period is usually longer in comparison to conventional medication. Immense patience 
while undergoing herbal treatment is needed. 
 
SOME DRUGS USED FOR DIABETICS MELLITUS 
Some herbs that have been confirmed by scientific investigation, which appear to be most 
effective, relatively non-toxic and have substantial documentation of efficiency. [67, c] 
 
 Cinnamon: It has insulin-like properties, which able to decrease blood glucose levels as well as 
triglycerides and cholesterol, all of which are important especially for type 2 diabetes patients. 
 
Bitter melon (Momordica charantia): Studies suggested that Asian Bitter Melon may lower 
blood glucose concentrations. Several compounds have been isolated from bitter melon that is 
believed to be responsible for its blood-sugar-lowering properties. These include charantin and an 
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insulin-like protein referred to as polypeptide-P, or plant insulin. It is believed that bitter melon 
acts on both the pancreas and in non pancreatic cells, such as muscle cells. 
 
Gynema Sylvestre: To treat diabetes, dried leaves are powdered together with Coriander fruit 
juice is extracted and given orally. These remedy has been used in India for treating diabetes for 
about 2000 years. Today in India it is being used to treat primarily type II diabetes and type I as 
well. Gymnema also improves the ability of insulin to lower blood sugar in both type I and type II 
diabetes. This herb is showing up in more and more over the counter weight loss products and 
blood sugar balancing formulas. 
 
Onion: Onion is a member of the lily family (Liliaceae). Experimental and clinical evidence 
suggests that onion consists of an active ingredient called APDS (allyl propyl disulphide). APDS 
has been shown to block the breakdown of insulin by the liver and possibly to stimulate insulin 
production by the pancreas, thus increasing the amount of insulin and reducing sugar levels in the 
blood. The additional benefit of the use of garlic is it beneficial cardiovascular effects. It is found 
to lower lipid levels, inhibit platelet aggregation and are antihypertensive. So the use of onion is 
recommended for diabetes patients. 
 
Fenugreek (Trigonella foenum-graecum):  Fenugreek is used both as an herb (the leaves) and 
as a spice (the seed). Pre-clinical and clinical studies have demonstrated the antidiabetic properties 
of fenugreek seeds. The fiber-rich fraction of fenugreek seeds can lower blood sugar levels in 
people with diabetes, and to a lesser extent, for lowering blood cholesterol. Additionally, the 
soluble fiber content of fenugreek may play a role in aiding weight control. 
 
Asian Ginseng: Asian ginseng is commonly used in traditional Chinese medicine to treat diabetes. 
It has been shown to enhance the release of insulin from the pancreas and to increase the number 
of insulin receptors. It also has a direct blood sugar-lowering effect and improves psycho-
physiological performance. 
 
Banaba (Lagerstroemia speciosa): Banaba possesses the powerful compound corosolic acid and 
tannins, including lagerstroemin that lends itself to the treatment of diabetes. These ingredients are 
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thought to stimulate glucose uptake and have insulin-like activity. The latter activity is thought to 
be secondary to activation of the insulin receptor tyrosine kinase or the inhibition of tyrosine 
phosphatase. It is a natural plant insulin, can be taken orally. 
 
Babhul (Acacia arabica): It is found all over India mainly in the wild habitat. The plant extract 
acts as an antidiabetic agent by acting as secretagouge to release insulin. 
 
Garlic (Allium sativum): Allicin, a sulfur-containing compound is responsible for its pungent 
odour and it has been shown to have significant hypoglycemic activity. This effect is thought to 
be due to increased hepatic metabolism, increased insulin release from pancreatic beta cells and/or 
insulin sparing effect, thus decreased fasting blood glucose, and triglyceride levels in serum in 
comparison to sucrose controls. S-allyl cystein sulfoxide (SACS), the precursor of allicin and 
garlic oil, is a sulfur containing amino acid, which controlled lipid peroxidation better than 
glibenclamide and insulin. It also improved diabetic conditions. SACS also stimulated In-vitro 
insulin secretion from beta cells isolated from normal rats 
 
Aloe (Aloe vera and Aloe barbadensis): Extracts of aloe gum effectively increases glucose 
tolerance in both normal and diabetic rats. Treatment of chronic but no single dose of exudates of 
Aloe barbadensis leaves showed hypoglycemic effect. Single as well as chronic doses of bitter 
principle of the same plant also showed hypoglycemic effect. This action of Aloe vera and its bitter 
principle is through stimulation of synthesis and/or release of insulin from pancreatic beta cells. 
This plant also has an anti-inflammatory activity in a dose dependent manner and improves wound 
healing in diabetes. 
 
Neem (Azadirachta indica): Hydroalcoholic extracts of this plant showed anti-hyperglycemic 
activity. Apart from having anti-diabetic activity, this plant also has anti-bacterial, antimalarial, 
antifertility, hepatoprotective and antioxidant effects. 
 
Mango (Mangifera indica): The leaves of this plant are used as an antidiabetic agent in Nigerian 
folk medicine, although when aqueous extract given orally did not alter blood glucose level in 
either normoglycemic or streptozotocin induced diabetes. The aqueous extract of Mangifera indica 
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possess hypoglycemic activity. This may be due to an intestinal reduction of the absorption of 
glucose. 
 
Holy Basil (Ocimum sanctum): It is commonly known as Tulsi. Since ancient times, this plant is 
known for its medicinal properties. The aqueous extract of leaves of Ocimum sanctum showed the 
significant reduction in blood sugar level in both normal and alloxan induced diabetes. Significant 
reduction in fasting blood glucose, uronic acid, total amino acid, total cholesterol, triglyceride and 
total lipid indicated the hypoglycemic and hypolipidemic effects of tulsi in diabetes 
 
Bhuiawala (Phyllanthus amarus): It is commonly known as Bhuiamala. Traditionally it is used 
in diabetes therapeutics. Methanolic extract of Phyllanthus amarus was found to have potent 
antioxidant activity. This extract also reduced the blood sugar in alloxanized diabetes 
 
 
 
ANTIDIABETIC ACTIVIY ARTOCARPUS HETEROPHYLLUS 
 
Hot water extract of mature jack leaves (artocarpus heterophyllus lam, family: moracea) is 
recommended by ayurvedic and traditional medical practitioners as a treatment for diabetes 
mellitus [69].  Previous studies have indicated that an extract of artocarpus heterophyllus improves 
the glucose tolerance in normal human subjects and diabetic patients [70] literature survey reveals 
that aqueous extract of artocarpus heterophyllus lam. Leaves shown to have anti-diabetic activity 
when investigated in rats[68].moreover flavonoid fraction of  Artocarpus heterophyllus leaf shown 
to have   hypoglycemic action [71].An ethyl acetate fraction of A. heterophyllus leaf extract exerts 
strong hypoglycemic activity in both normoglycaemic and diabetic rats[72].Jack Fruit n-butanolic 
extracts exert hypoglycemic and hypolipidemic effects in STZ-diabetic rats through an 
antioxidative pathway that might be referred to their flavonoid contents.[73] 
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ANTIDIABETIC ACTIVIY OF PIPER NIGRUM 
 
Ethanolic Leaves Extract of Black Pepper (Piper Nigrum) on Alloxan-Induced Diabetic Rats 
shown to have Hypoglycemic Potentials [74]. Piperine has the potential to be used as an antidiabetic 
agent. Its acute effects of raising blood glucose could also be used beneficially by using it in 
combination with known antidiabetics to counteract their adverse effect of hypoglycemia. The sub-
acute administration of piperine has statistically significant antihyperglycemic activity while 
acutely it raises blood glucose at high doses. [75] Oxidative stress plays a key role in diabetes, and 
treatment with P. nigrum and V. rosea are useful in controlling not only the glucose and lipid levels 
but these components may also be helpful in strengthening the antioxidants potential [76]  
 
NEED OF THIS STUDY 
 
Literature survey reveals that Artocarpus hetrophyllus and Piper nigrum are extensively used in 
traditional medicine and various isolated constituents from these plants are also used. However, 
the toxicological and antidiabetic status of their combination have not been investigated yet .the 
present study was planned to evaluate  the toxicological and antidiabetic statues of this  formulation 
using streptozotocin induced diabetics rat  with a view to provide scientific evidence.  
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2. PLANT PROFILE 
 
  
ARTOCARPUS HETEROPHYLLUS LAM. – JACKFRUIT 
TAXONOMICAL CLASSIFICATION 
Table:  – Taxonomical classification of Artocarpus Heterophyllus Lam [e] 
Rank Scientific Name and Common Name 
Kingdom Plantae – Plants 
Subkingdom Tracheobionta – Vascular plants 
Superdivision Spermatophyta – Seed plants 
Division Magnoliophyta – Flowering plants 
Class Magnoliopsida – Dicotyledons 
Subclass Hamamelididae  
Order Urticales  
Family Moraceae – Mulberry family 
Genus Artocarpus J.R. Forst. & G. Forst. – breadfruit 
Species Artocarpus heterophyllus Lam. – jackfruit 
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Description: [f] 
 
Jackfruit is a handsome tree that can grow up to 9-21 m (70 ft) tall, with evergreen, alternate, 
glossy and leathery leaves to 22.5 cm (9 in) in length. The tree is monoecious, meaning that male 
and female flowers appear on the same tree. Tiny male flowers are borne in oblong clusters, while 
the female flower clusters are rounded. The largest of all trees produces fruits that can reach 20-
90 cm (3 ft) in length and weighing 4.5-20 or as much as 50 kg (110 lbs). All parts of the tree 
contain sticky, white latex.  The fruit has a unique compound structure. The exterior of the fruit is 
green or yellow when ripe and composed of numerous hard, cone-like points attached to a thick 
and rubbery, pale yellow or whitish wall. The interior consists of large fully developed "bulbs" 
(called perianths) of yellow, banana-flavored flesh, massed among narrow ribbons of thin, tough 
undeveloped perianths and a central, pithy core. Each bulb encloses a smooth, oval, light-brown 
"seed" covered with a thin white membrane. The seed is thick, white and crisp within. One single 
fruit can have from 100 to 500 seeds inside.  There is one other unique and peculiar aspect about 
the Jackfruit: when fully ripe, the unopened fruit emits a strong disagreeable odor, resembling that 
of decayed onions, while the pulp of the opened fruit smells of pineapple and banana 
 
Growth & Distribution [104] 
Jackfruit has been cultivated since prehistoric times and has naturalized itself in many parts of the 
tropics, particularly in Southeast Asia, where it is today an important crop of India, Myanmar, 
China, Sri Lanka, Malaysia, Indonesia, Thailand and Philippines. It is also grown in parts of Africa, 
Brazil, Surinam, Caribbean, Florida and Australia. It has been introduced to many Pacific islands 
since post European contact and is of particular importance in Fiji, where there is a large population 
of Indian descent 
Phytochemistry 
 
The Artocarpus heterophyllus contains various chemical constituents as several flavones colouring 
matters, morin, dihydromorin, cynomacurin, artocarpin, isoartocarpin, cyloartocarpin, 
artocarpesin, oxydihydroartocarpesin, artocarpetin, norartocarpetin, cycloartinone and 
artocarpanone [105] . The heart wood on analysis yields moisture 6.7%, glucosides 38.0%, lipids 
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0.7%, albumin 1.7% and cellulose 59.0 % [106] . The plant also contains free suger (sucrose), fatty 
acids, ellagic acid and some essential Amino acids like Arginine, Cystine, Histidine, Leucine, 
Lysine, Metheonine, Theonine, Tryptophan etc. [107] . Bark from main trunk contains betullic acid 
and two new flavone pigments, cycloheterophyllin (C 30 H 30 O 7) 
[108] . Triterpenic compounds like 
cycloartenyl acetate, cycloartenone are also reported [109] . Heterophylol a phenolic compound with 
novel skeleton was obtained from Artocaipus heterophyllus [110] . There is only 3.3% tannin in the 
bark, which is occasionally made into cordage or cloth. The leaves and stem show the presence of 
sapogenins, cycloartenone, cycloartenol, β-sitosterol [111] and tannins, they show estrogenic 
activity. A root contains β-sitosterol, ursolic acid, Betulinic acid and cycloartenone [112] . 
 
Jacalin, the major protein from the Artocarpus heterophyllus seeds, is a tetrameric two-chain lectin 
combining a heavy chain of 133 amino acid residues with a light β chain of 20-21 amino acid 
residues. It is highly specific for the O-glycoside of the disaccharide Thomsen-Friedenreich 
antigen (Galβ1- 3GalNAc), even in its sialylated form. This property has made jacalin suitable for 
studying various O-linked glycoproteins, particularly human IgA1 [113] . Jacalin's uniqueness in 
being strongly mitogenic for human CD4 + T lymphocytes has made it a useful tool for the 
evaluation of the immune status of patients infected with human immunodeficiency virus HIV-1 
[114] . Two novel 2', 4', 6'--trioxygenated flavanones, heteroflavanones A and B were isolated from 
the root bark of Artocarpus heterophyllus [115, 116]. Three phenolic compounds were characterized 
as artocarpesin, norartocarpetin and oxyresveratrol by spectroscopic methods and through 
comparison with data reported in the literatures [117] . The composition of carotenoids of 
A.heterophyllus is carotenes β-carotene, α - carotene, β-zeacarotene, α-zeacarotene and β-carotene-
5, 6-epoxide and a dicarboxylic carotenoid, crocetin were identified [118] . 
 
Traditional uses  
The leaves are useful in fever, boils, wounds and skin diseases. The young fruits are acrid, 
astringent, and carminative. The ripe fruits are sweet, cooling, laxative, aphrodisiac and also used 
as a brain tonic. The seeds are, diuretic, and constipating. The wood is nervine, antidiabetic, 
sedative and is useful in convulsions [119] . The latex is useful in dysopia, ophthalmic disorders and 
pharyngitis and also used as antibacterial agent [120] . The ash of Jackfruit leaves is used in case of 
ulcers. The dried latex yields artostenone, convertible to artosterone, and a compound with marked 
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androgenic action. Mixed with vinegar, the latex promotes healing of abscesses, snakebite and 
glandular swellings [121] . The root is a remedy for skin diseases and asthma. An extract of the root 
is taken in cases of fever and diarrhea. The bark is made into poultices. Heated leaves are placed 
on wounds. The wood has a sedative property and its pith is said to be abortifacient. Latex is used 
as an antiinflammatory agent [122] 
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 PLANT PROFILE 
 
  
PIPER NIGRUM L – BLACK PEPPER 
 TAXONOMICAL CLASSIFICATION 
Table:  – Taxonomical Classification of Piper Nigrum L [g] 
Rank Scientific Name and Common Name 
Kingdom Plantae – Plants 
Subkingdom Tracheobionta – Vascular plants 
Superdivision Spermatophyta – Seed plants 
Division Magnoliophyta – Flowering plants 
Class Magnoliopsida – Dicotyledons 
Subclass Magnoliidae 
Order Piperales 
Family Piperaceae – Pepper family 
Genus Piper L. – Pepper 
Species Piper nigrum L. – Black Pepper 
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GEOGRAPHY AND DISTRIBUTION [i] 
Black pepper is native to the Western Ghats of Kerala State in India, where it grows wild in the 
mountains. It is cultivated all over the tropics as a commercial crop. Vietnam, Indonesia, Brazil 
and India are the major producers. 
DESCRIPTION 
Overview: A climber that grows to a height or length of 10 m or more. Once the main stem is 
established it grows many side shoots to create a bushy column. The plants form short roots, called 
adventitious roots, which connect to surrounding supports. 
Leaves: Almond-shaped, tapering towards the tip, dark green and shiny above, paler green below, 
arranged alternately on the stems. 
Flowers: Borne in clusters along flowering stalks known as spikes. 50–150 whitish to yellow-
green flowers are produced on a spike. 
Fruits: Round, berry-like, up to 6 mm in diameter, green at first but turning red as they ripen, each 
containing a single seed. 50–60 fruits are borne on each spike. 
CHEMICAL COMPOSITION OF BLACK PEPPER [123] 
Compounds responsible for odor, aroma and pungency in black pepper is found out from GC-
MS analysis. It contains α-terpineol (Floral), Acetophenone (Irritant, sharp), Hexonal (Green 
apple), Nerol (Fresh, Floral, Herbal), Nerolidol (Mild spicy, Rooty), 1, 8–cineol (Camphory), 
Dihydrocarveol (Warm, Woody), Citral (Citrussy), α–pinene (Terperic, Oxidised), Piperolnol 
(Sweet, Floral) [124] 
It contains lignans, alkaloids, flavonoids, aromatic compounds and amides [125]. It also contains 
essential oil up to 3.5% and this oil constitutes sabinene, pinene, phellandrene, linalool and 
limonene. It also has piperine which is a weak basic substance. Chavicine is an isomer of piperine 
[126]. Piperine and Chavicine are not responsible for the aroma of the black pepper but piperine 
imparts pungency to the black pepper [127, 128].    
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Vitamins content in black pepper: Choline, Folic acid, Niacin, Pyridoxine, Riboflavin, Thiamin, 
Vitamin A, and Vitamin C   Vitamins A, Vitamin E, Vitamin K are the major vitamins found in 
the black pepper. 
Minerals content of black pepper: Calcium, Copper, Iron, Magnesium, Manganese, Phosphorus, 
Zinc are the main minerals found in the black pepper. 
USES [i] 
Food- This hotly pungent spice is one of the earliest known and most widely used spices in the 
world today. It is used as flavoring, particularly for savoury foods, meat dishes, sauces and snack 
foods. It is also used as a table condiment. Black pepper is also used to produce pepper oil and 
oleoresin, which are frequently used in the production of convenience foods and sometimes also 
for perfumery. 
Traditional medicine- Black peppercorns feature as remedies in Ayurveda, Siddha and Unani 
medicine in South Asia. They are most frequently used as an appetizer and to treat problems 
associated with the digestive system, particularly to eradicate parasitic worms. Some traditional 
uses of black pepper are supported by scientific evidence. 
In Ayurvedic medicine, black pepper has been used to aid digestion, improve appetite, treat 
coughs, colds, breathing and heart problems, colic, diabetes, anaemia and piles. Stomach ailments 
such as dyspepsia, flatulence, constipation and diarrhoea are all treated with black pepper. 
Black pepper has been used as a remedy for cholera and syphilis. It has also been used in tooth 
powder for toothache, and an infusion of black pepper has been suggested as a remedy for sore 
throat and hoarseness. Black pepper may be chewed to reduce throat inflammation. Externally, it 
has been applied as a paste to boils and to treat hair loss and some skin diseases. Oil of pepper is 
reputed to alleviate Black pepper has been given by inhalation to comatose patients. It is also 
believed to be useful against hepatitis, urinary and reproductive disorders.  
In Unani medicine, black pepper has been described as an aphrodisiac and as a remedy to alleviate 
colic. 
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Black pepper contain compounds called alkaloids. One of these is piperine, reported to act as a 
central nervous system depressant and to have anti-fever, pain-relieving, anti-inflammatory and 
insecticidal effects. Some experiments suggest black pepper and its constituent piperine may have 
potential in the treatment of vitiligo (loss of skin pigment) as it helps increase pigmentation in the 
skin. Black pepper is also reported to have anti-fungal and anti-oxidant properties. [i] 
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3. LITERATURE REVIEW 
 
Nazli shahin et al., 2012 Investigated the antidiabetic property of the aqueous leaves extract of 
Artocarpus. Heterophyllus at dose of 250 mg/kg for 21 days to diabetic rats. The study showed 
significant reduction of serum glucose, total cholesterol, whereas significant increased level of 
high density lipoprotein. The leaf extract showed antidiabetic and Antihyperlipidemic by 
restoration of blood glucose level and biochemical profiles. [81] 
 
Chandrika U. G et al., 2006 Reported that flavonoid fraction of hot water extract of mature jack 
leaves (Artocarpus heterophyllus) caused the hypoglycemic effect at a dose of 50 mg/Kg, both in 
normal and alloxan-diabetic rats. The hypoglycemic effect of the flavonoid fraction of jack leaf 
(49%) is higher than that of tolbutamide (27.0%). Administering the flavonoid fraction for 3 
months had no significant effects on liver function while the histology of liver, kidney and heart 
revealed no damage. [82] 
 
Om Prakash et al., 2013 Evaluated the Analgesic and Immunomodulator activity of methanolic 
and aqueous  leaves extract  of Artocarpus heterophyllus Lam by using Eddy’s hot plate method 
and Swimming endurance test at the dose levels of 250 and 500mg/kg in Swiss albino mice 
respectively.Studies indicate that the methanolic extract of the leaves of Artocapus heterophyllus 
possess analgesic and immunomodulator activity up to significant level which is justified by 
Eddy's hot plate and Swimming endurance test.[ 83] 
 
Efrilia Tanjung et al., 2015 Perfomed the antidiabetic and antioxidant activity of aqueous extract 
of Jackfruit.The antidiabetic activity were determined by inhibition of haemoglobin glycation 
method. Phytochemical constituent like ascorbic acid, β-carotene and lycopene also determined. 
Antioxidant activity was measured by hydroxl radical and hydrogen peroxide scavenging activity, 
and chellating effect of ferrous iron [84] 
 
Sureka Chackrewarthy et al., 2012 Investigated Hypoglycaemic and Hypolipidaemic Effects of 
an Ethylacetate Fraction of Artocarpus heterophyllus Leaves. The leaf extract exerts strong 
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hypoglycaemic activity in STZ induced diabetic rats when compared with a standard drug 
Glibenclamide (0.6 mg kg-1 bw-1) and it also show improvement in the hyperlipidaemia by 
lowering of serum total cholesterol and triglycerides [d] 
 
Meshram R. L et al., 2011 Investigated  comparative evaluation for in vitro Antioxidant activity 
from Artocarpus heterophyllus Lamk and alanites aegyptiaca L.The  antioxidant activity is 12.34 
% for acetone extract from the seed of Artocarpus whereas, chloroform extract of the same showed 
14.87% inhibition.[ 85] 
 
Sindhu.S.Nair et al., 2013 Evaluated the In Vitro Anti diabetic Activity methanolic extracts of 
bark of Cinnamomum zeylanicum, , leaves of Piper betle, leaves of Artocarpus heterophyllus and 
fruit of Artocarpus altilis.The results of the work indicate that the selected plants possessed 
considerable invitro anti diabetic activity[86] 
 
Anjali Ruikar et al., 2015 Investigated the antioxidant potential of ethanolic extract of bark of 
Artocarpus heterophyllus. DPPH radical scavenging assay and Superoxide radical scavenging 
assay were performed using ascorbic acid as standard. Hydroxy radical scavenging assay, Nitric 
radical assay and Hydrogen peroxide assay were studied with curcumin as standard.Reducing 
power assay was carried out with BHT as standard.Trolox Equivalent Antioxidant capacity was 
also investigated. The results of different in vitro antioxidant activity assays indicated that the bark 
extract possessed appreciable free radical scavenging effects. [87] 
 
Haidy S. Omar et al., 2011 Investigated the potential hypoglycemic and hypolipidemic activities 
of Artocarpus heterophyllus (jack fruit) leaf extracts of both 70% ethanol extract and n-butanol 
extracts and compared to the hypoglycemic reference drug Glibenclamide (600 µg kg-1 day-1). 
Diabetes was induced in the rats by a single intraperitoneal (i.p.) injection of freshly prepared STZ 
(60 mg/kg b. w.) in normal saline He conclude from this study that ethanolic and butanolic extract 
exert hypoglycemic and hypolipidemic effects in STZ-diabetic rats through an antioxidative 
pathway that might be referred to their flavonoid contents[88]  
M. Kaleem et al., 2005 Orally administered the aqueous extract of Piper nigrum seeds and Vinca 
rosea flowers to alloxan induced diabetic rats once a day for 4 weeks. These treatments lead to 
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significant lowering of blood sugar level and reduction in serum lipids suggesting  that treatment 
with this drug are useful in controlling not only the glucose and lipid levels but these components 
may also be helpful in strengthening the antioxidants potential[89] 
Onyesife et al., 2014 Investigated hypoglycemic activity of ethanolic extract of piper nigrum 
leaves on alloxan induced diabetics rats for a period of 21days and the result  suggest that the piper 
nigrum leaves possess anti-diabetic properties[90] 
Shanmugapriya K et al., 2014 Studied the activity of ethanolic extract of Piper nigrum leaves 
against Dalton lymphoma ascites in Swiss albino mice. Phytochemicals analysis, Antimicrobial 
and antioxidant activities were evaluated by the standard methods. Anticancer activity was 
evaluated by liver histopathology, serum biochemical parameters.The present study suggested that 
anti-cancer activity of ethanolic extract might be mediated through scavenging of free radicals and 
it has a significant potential to use as a natural antioxidant agent due to its significantly higher 
amount of phenolic content. [91] 
 
Gayatri Nahak et al., 2011 Evaluated Phytochemical and a comparative study of the Antioxidant 
activity of ethanolic and methanolic extracts of dried fruits of Piper cubeba and Piper nigrum. The 
results of antioxidant activity indicate that higher free radical scavenging activity in ethanolic 
extracts of Piper cubeba in comparison to Piper nigrum due to presence of phytochemical 
constituents especially polyphenols.[92] 
 
K Shanmugapriya et al., 2012 Evaluated antioxidant activity and antimicrobial activity against 
some pathogenic microbes. The result revealed that the leaf extract have potential antioxidant 
activity which is determined by free radicle scavenging method which is due to the presence of 
flavonoid. The extract also have activity against gram positive and gram negative bacteria and also 
against fungi which is evaluated by disc diffusion method. [93] 
O. Onyesife Chioma et al., 2014 Evaluated the lethal toxicity and histology assessment of the 
organs of diabetic rats treated with different doses ethanolic extract of Piper nigrum was analyzed. 
The acute toxicity (LD50) test result showed that the leaves were not toxic up to 5000mg/kg body 
weight after 24 h of constant observation. The histological sections of the liver and kidney of 
extract treated rats showed no remarkable histological changes compared to Diabetic untreated 
Antidiabetic and Toxicity Assessment Of Combination of Piper nigrum And Artocarpus hetrophyllus 
R.V.S College Of Pharmaceutical Sciences, Dept. Of Pharmacology, Sulur, Coimbatore          Page 58 
which is an indication that Piper nigrum extract is safe and possess no threat to the organs of 
metabolism. [94] 
 
Divya Pingili et al., 2012 Investigated, methanolic and hydro alcoholic polyherbal extracts having 
bark of Terminalia arjuna, Piper nigrum Linn seeds And Cuminum cyminum Linn seeds for their 
in vitro antioxidant activity by DPPH and superoxide radical scavenging method and in vitro 
antidiabetic activity by α glucosidase and α amylase inhibitory method; and anticancer activity by 
MTT assay against A549 human lung cell carcinoma. Among the evaluated six polyherbal extracts 
for anticancer activity, the combination of methanolic extract of Terminalia arjuna and piperine 
(S1+ P2) treatment have showed potent antitumor property than the standard Cisplatin and it may 
be due to the enhanced bioavailability of the species when given in combination[95] 
 
Shubham Atal et al., 2012 Studied the the effect of Piperine per Se on blood glucose level in 
Alloxan-Induced Diabetic Mice.The result revealed that piperine has potential  antidiabetic 
activity, if given repeatedly at the appropriate doses over a period of time. Its acute effects of 
raising blood glucose could also be used beneficially by using it in combination with known 
antidiabetics to counteract their adverse effect of hypoglycemia. [96] 
 
O. Onyesife et al., 2014 Evaluated the Serum Lipid Peroxidation and Antioxidant Enzymes 
Activities in Diabetic Rats using ethanolic extract of piper nigrum leaves. The results confirmed 
that the untreated diabetic rats were subjected to oxidative stress as resulting in low superoxide 
dismutase, catalase and glutathione activities. The ethanol extract of Piper nigrum leaves shown 
to increased activities of superoxide dismutase and catalase and glutathione levels of the diabetic 
rats after 21 days treatment. [97] 
 
Popi patilaya et al., 2012 Studied Effects of standardized fractions of piper nigrum on the growth 
of mycobacterium tuberculosis H37rv strain using tetrazolium micro plate assay method to 
determine the minimum inhibitory concentration. The results reveals that the ethyl acetate fraction 
of piper nigrum leaf has potential activity against mycobacterium tuberculosis. The ant 
mycobacterial activity of the fraction might be through the disruption of the cell wall of 
mycobacteria [98] 
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A.Dinakar, P.D et al., 2010 Studied the inhibition of thioacetamide –induced liver Fibrosis using 
piper nigrum Linn seeds. The extract reduced the level hydroxyproline which is a good marker of 
fibrosis and the extract show anti fibrotic activity [99] 
 
S.K. Shiva Rani et al., 2013 Evaluated the antimicrobial activity of piperine isolated from piper 
nigrum seeds. In the present study the antibacterial activity was measured by agar well diffusion 
method and antifungal activity by poisoned food technique. Piperine showed antimicrobial activity 
against all tested bacteria and fungus suggesting the use of piperine as antimicrobial agent [100] 
 
Kaleem M et al., 2008 Investigated the Annona squamosa extract on certain biochemical markers 
in streptozotocin (STZ) induced diabetes mellitus in rats by a single intraperitoenal (i.p.) injection 
of freshly prepared STZ (55 mg/kg body weight of rats) in 0.1 M citrate buffer (pH 4.5). The 
results shown that extract has an antihyper glycaemic effect and consequently may alleviate liver 
and renal damage associated with STZ-induced diabetes mellitus in rats [101] 
 
Shaik Abdul Nabi et al., 2013 Evaluated Antidiabetic and antihyperlipidemic activity of Piper 
longum root aqueous extract in STZ induced diabetic rats by intraperitoneal administration of STZ 
(single dose of 50 mg/kg b.w.) dissolved in freshly prepared 0.01M citrate buffer, pH 4.5. From 
the results it is concluded that the plant extract is capable of managing hyperglycemia and 
complications of diabetes in STZ induced diabetic rats [102] 
 
C. Hari kumar et al., 2010 Evaluated the antidiabetic activity using the extracts seeds of Eugenia      
jambolana, fruits of momordica charantia, and leaves of ocimum sanctum in the ratio 1:1:1 to get 
a polyherbal Preparation. Treatment with the polyherbal Preparation for 11 days in diabetic 
animals has shown significant decrease in serum glucose, AST, ALT and biochemical parameters 
(urea, creatinine, triglycerides and cholesterol) levels in comparison to control animals [103] 
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4. AIM AND OBJECTIVE 
 
AIM 
    To assess the antidiabetic and toxicological studies of the combination of Piper nigrum and 
Artocarpus hetrophyllus. To achieve this primary aim we set a following objective. 
 
OBJECTIVE 
1. To evaluate the taxonomical  studies 
2. To study the pharmacognostical property of  Piper nigrum and Artocarpus 
hetrophyllus 
3. To evaluate the various toxicological study –accute and sub acute toxicity-by animal 
models 
4. To evaluate the antidiabetic activity of the combnation of  Piper nigrum and 
Artocarpus hetrophyllus  by stz induced animal models  
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5. PLAN OF WORK 
Literature review 
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It is divided into following phase-  
  
PHASE I: Taxonomical studies.  
 
 Collection of plants. 
 Authentication of plants. 
 Powdered the leaves materials 
 
PHASE II: Pharmacognostical studies.  
 
 Successively solvent Extraction.  
 Alcohol (ethanol).  
 Preliminary Phytochemistry screenings.  
 Alkaloids 
 Saponins 
 Tannins 
 Amino acid 
 Flavonoids 
 Terpenoids 
 Protein 
 Steroids  
 
PHASE III: Pharmacological studies.  
 
 Acute toxicity studies (as per OECD guidelines) 
 Sub acute toxicity studies (as per OECD guidelines) 
 Induces diabetic in rats by STZ  
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 Measuring the body weight  
 Measuring the water intake 
 Measuring the food intake 
 Determination of lipids  
 Triglyceride  
 Total cholesterol  
 HDL  
 VLDL  
PHASE IV: Result and Documentation.  
Evolution of statistical significance result by computer aided program and systemic 
documentation. Values were presented as mean SEM Data were analyzed using of variance 
(ANOVA) and group means were compared with Turkey’s post hoc Multiple Comparison Test 
using SPSS software version 17. P<0.05 is considered as significant. 
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6. MATERIALS AND METHOD 
 
           Chemicals:- 
 Streptozotocin 
 Glibenclamide 
 Petroleum ether 
 Ethanol 
 Benzene 
 Chloroform 
 Studies were carried out in albino rats. 
Instruments:- 
 Soxhlet Apparatus 
 Hot air oven 
 Actophotometer 
 Rotarod Apparatus 
 Analgesiometer 
 Glucometer 
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TAXONOMICAL STUDIES.  
 
1) Collection of plants.  
Leaves of Artocarpus Heterophyllus and Piper Nigrum were collected from the region of 
kanjrapally, kottayam in Kerala, India.  
The freshly collected leaves were thoroughly cleaned and soaked in fresh water repeatedly to 
separate mud particles sticking on to plant constituents. The plants materials collected were cut 
into small bits of about 2-3 in size.  The leaves were powdered with a mechanical grinder and this 
powder was subjected to various studies for which the materials and methods which is presented 
below.  
 
2) Authentication of plant.  
The dried whole plant of Artocarpus Heterophyllus and Piper Nigrum were authenticated 
by Dr.  M. V. Krishnaraj, Department of Botany, Baselius College Kotayam 
 
PHARMACOGNOSTICAL STUDIES. 
 
EXTRACTION PROCEDURE. 
  
 
 
Figure : Assembly extraction Apparatus 
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The crude weighed powder were mixed and placed in the Soxhlet apparatus by using ethanol. From 
the 500gm of crude powder was extracted with 2.5 liter of ethanol (60 – 80) by continuous hot 
percolation using Soxhlet apparatus. This can be continued up to 24 hours. After the completion 
of extraction process, Soxhlet is removed and the residue obtained is stored in the dissector.  
 
PHYTO CHEMICAL SCREENING[129-131]  
The plant may be contain the compound such as carbohydrate, protein, and lipids. It also contains 
the compound like. Tannins, glycosides, alkaloids, Volatiles oils and other important compounds 
which are utilized by man as food and medicines. These compounds are responsible for its 
medicinal properties  
 
TEST FOR CARBOHYDRATES  
Molish test:- 
The powdered sample was added with 1 ml of alpha napthol solution along with conc 
Sulphuric acid solution in the test tube, reddish colour was produced at the junction between 2 
liquid shows the presence of carbohydrate.  
Fehling test:- 
To the powdered sample was added with both Fehling A and Fehling B solution and placed 
in the water bath for a sufficient time. This shows the brick red colour. It shows the presence of 
carbohydrate.  
Benedicts test:- 
To the powdered sample add 8 drops of benedict’s reagents and boil the sample vigorously 
for 5 min, it shows the red ppt. indicating the presence of carbohydrate.  
 
TEST FOR ALKALOIDS  
Powdered sample was taken in a test tube and add few drops of hydrochloric acid and 
filtered. The filtrate was tested with various alkaloid agents,  
Mayer’s reagents:-  
To the above filtrate add small quantity of Mayer’s reagent to form cream precipitate. This 
shows the presence of alkaloids.  
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Dragendorffs reagents:- 
To the above filtrate add small amount of Dragendorffs reagent and it forms an orange 
brown precipitate. This shows the presents of alkaloids.  
 
TEST FOR FLAVONOIDS  
The plant extract is filtered and add 5 ml of dilute ammonia solution and followed by the 
addition of concentrated sulphuric acid. It forms a yellow colour. It shows the presence of 
flavonoids.  
 
TEST FOR STEROIDS  
Salkowaski test:- 
A small volume plant extract is mixed with chloroform and the same volume of sulphuric 
acid is added on it. Cherry red colour was obtain in the chloroform layer. This shows the sample 
contain steroids.  
Libbbermann burchatd test:-  
The extract is dissolved in 2 ml of chloroform, 10 drops of acetic acid and conc. Sulphuric 
acid were added. The solution becomes reddish colour then it turns to bluish green colour. This 
shows that the plant extract has the presence of steroids.  
 
TEST FOR TANNINS  
Few amount of plant extract is treated with vanillin hydrochloric acid reagent. It forms, 
pink or red colour due to the formation of phloroglucinol, it indicate the presence of tannins.  
 
TEST FOR PROTEIN 
Mellon’s reagents:-  
Mellon’s reagents (mercuric nitrate in nitric acid containing a trace of nitrous acid) usually 
yields a white precipitate on addition to a protein solution which turns red on heating.  
Ninhydrin Test:-  
Add 2 drops a freshly prepared 0.2% ninhydrine reagent to the extract and heated. 
Development of blue colour may indicate the presence of peptide, amino acid (Protein).  
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TEST FOR GLYCOSIDES  
Keller- killani test:- 
To the small quantity of extract, acetic acid was dissolved and adds few drops of ferric chloride 
and transferred to the surface of conc Sulphuric acid. At the junction, reddish brown colour was 
formed, which gradually becomes blue indicates the presence of cardiac glycosides.  
 
TEST FOR SAPONINS.  
Foam test:- 
1 ml of extract solution is diluted separately with distilled water to 20 ml and shaken in a 
graduated cylinder for 15 minutes. A 1 cm layer of foam indicates the presence of Saponins. 
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TOXICOLOGICAL STUDIES. 
 
 
TOXICITY STUDY [132].  
 
ACUTE TOXICITY STUDY 
Experimental Protocol  
Guideline    : OECD-423  
CPCSEA Ref. No   : IAE1012/c/06/CPCSEA  
Test     : Limit test  
Species    : Rattus norvegicus  
Strain     : Albino Wistar rats  
Number of animals   : 10 animals (5 for each extract)  
Sex     : Female  
Initial dose    : 200mg/kg  
Route of administration  : Oral  
Duration    : 4 hr close observation, followed by 14 days observation  
Others    : Body weight, mortality status  
Parameters    : CNS, ANS and behavioral changes  
Blood collection   : Not needed  
Sacrifice    : On day 14 after oral administration  
 
Table 6:- EXPERIMENTAL DESIGN FOR ACUTE TOXICITY STUDY 
GROUP  
 
DOSE (mg/kg)  
 
GROUP 1 50 
GROUP 2 200 
GROUP 3 2000 
GROUP 4 Control 
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STUDY DESIGN  
Selection of Test animal  
Female adult Wistar rats of 8-12 weeks are selected. Nulliparous and non-pregnant animals were 
obtained from the centralized animal house of RVS College of Pharmaceutical sciences, Sulur and 
they are acclimatized for holding one week prior to dosing.  
 
Housing and feeding conditions  
Temperature - As per OECD GUIDELINE-420 the temperature of animal house is maintained at 
220C±30C.  
Humidity - The relative humidity of animal room maintained at 50-60% preferably not exceeds 
70% (OECD guidelines-420, 2001). Otherwise there may be chances of developing lesions such 
as ring tail and food consumption may be increased.  
Light – The sequence of light used is 12 hrs light and 12 hrs dark.  
Caging – Polypropylene cages with solid bottom and walls. The lids are made up of stainless steel 
grill which is capable to hold both feed and water.  
Feeding condition and feed – Sterile laboratory feed (ad libitum) and water daily. The feed used 
is brown coloured chow diet.  
 
Drug Administration  
Animals are fasted prior to dosing (food but not water should be withheld for overnight).After that 
animals are weighed and the test substance administered. The healthy rats has been taken and 
divided into 4 different groups. The ethanolic extract of the leaves of Artocarpus Hetrophyllus and 
leaves of Piper Nigrum were mixed in the ratio 1:1. Then the extract was dissolved in ethanol. The 
test substance is administered in a single dose by oral gavages, using a curved and ball tipped 
stainless steel feeding needle.  
 
Clinical observation  
All animals were monitored continuously with special attention for 4 hrs after dosing for signs of 
toxicity. Additional observations are also done for the next 14 days for any other behavioral or 
clinical signs of toxicity. Weight changes are calculated. At the end of the test animals are weighed 
and then humanely killed and LD50 values are established.  
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SUB ACUTE TOXICITY STUDY 
 
Experimental Protocol  
Guideline    : OECD-407  
CPCSEA Ref. No   : 1012/c/06/CPCSEA  
Species    : Rattus norvegicus  
Strain     : Albino Wistar rats  
Number of animals   : 10 for each groups 
Sex     : Male/Female  
Route of administration  : Oral  
Duration    : 28 days  
No. of blood collection  : 2  
Duration of blood collection  : 0th day, 28th day  
Blood collection route  : Retro orbital 
Sacrifice    : After 28 days of oral administration  
Body weight recording  : weekly intervals  
 
Table 7:-EXPERIMENTAL DESIGN FOR SUBACUTE TOXICITY STUDIES 
GROUPS DOSE NO. OF ANIMALS 
GROUP 1 High dose 10(5M+5F) 
GROUP 2 Low dose 10(5M+5F) 
GROUP 3 Medium dose 10(5M+5F) 
GROUP 4 Control 10(5M+5F) 
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STUDY DESIGN  
Selection of Animals  
Male and Female rats were selected and are acclimatized for 5 days prior to the start of study. The 
females are nulliparous and non-pregnant. At the commencement of study the weight variation of 
animals used minimal and not exceed ± 20 % of the mean weight of each sex. Repeated dose oral 
study was conducted as a preliminary to a long term study preferably animals from the same strain 
and source were used in both studies.  
Housing and feeding conditions  
The temperature in the experimental animal room was maintained at 220C ±30C. The relative 
humidity was 50-60% (not exceed 70%) and the lighting sequence was 12 hrs light and 12 hrs 
dark. For feeding, conventional laboratory diet was used with an unlimited supply of drinking 
water. Animals were housed in small groups of same sex (NMT 5 animals in each cage)  
Preparation of animals  
Healthy young adult animals were randomly assigned to control and treatment groups. Cages were 
arranged in such a way that possible effects due to cage placement were minimized. The animals 
were identified uniquely and kept in their cages for five days prior to the start of the study to allow 
for acclimatization to the laboratory conditions.  
 
TABLE 8:-DOSE OF DRUG FOR SUB ACUTE TOXICITY STUDIES 
GROUPS 
 
DOSE (mg/kg) 
 
GROUP 1 100 
GROUP 2 200 
GROUP 3 400 
GROUP 4 Control 
 
Dose Administration  
The leaf extracts were administered by oral gavages.The ethanolic extract of the leaves of 
Artocarpus Hetrophyllus and leaves of Piper Nigrum were mixed in the ratio 1:1. Then the extract 
was dissolved in ethanol. Ten animals (5 males and 5 females) were used at each dose level for 
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each extracts. Three test groups and a control group were used for both extracts and the highest 
dose level was chosen with the aim of inducing toxic effects but not death or severe suffering. 
Thereafter a descending sequence of dose levels selected with a view to demonstrating dosage 
related response and non-observed-adverse effects at the lowest dose level (NOAEL). The animals 
were dosed with test substance daily 7 days each week for a period of 28 days.  
 
FUNCTIONAL OBSERVATIONAL BATTERY (FOB) OBSERVATIONAL 
PROCEDURES 
 
Home-cage observation  
The animals were observed closely from outside the cages without agitating them; body position, 
respiration, clonic involuntary movement, tonic involuntary movement, vocalizations and 
palpebral closures were noted [133].  
Hand-held observations  
The reactions of the animals were observed when they were removed from their cages and held. 
Reactivity, palpebral closure, lacrimation, salivation and pilo erection were noted. Detail any 
finding related to dirtiness of hair cast, bite marks, missing nails, gauntness (stomach could be 
touched, median vertebrae protrude) or death (findings) [134].  
Open field activity  
Each animal was gently placed in the centre of a field and made the following 10 observations for 
3 minutes [135]  
1. Rearings  
2. clonic involuntary movement  
3. Tonic involuntary movement  
4. Gait  
5. Movements  
6. Arousal  
7. Stereotype  
8. Abnormal behavior  
9. Defecations  
10. Urinations.  
Antidiabetic and Toxicity Assessment Of Combination of Piper nigrum And Artocarpus hetrophyllus 
R.V.S College Of Pharmaceutical Sciences, Dept. Of Pharmacology, Sulur, Coimbatore          Page 74 
Stimulus response  
Approach response; touch response, eyelid reflex, pinna reflex, sound response, tail pinch 
response, tail flick latency, pupillary reflex, righting reflex observations were carried out:  
Eyelid reflex assessment  
The animal’s eyelid was touched with a dull object (cotton buds) and blinking response was noted.  
Pinna reflex assessment  
This is to assess the sensor motor activity of the animals. The fine object (cotton) was slightly 
touched inside the ear of the animals. The time duration taken for the response was noted.  
Sound response assessment  
In order to assess the sensor motor activity of the animals, the fingers snapped above and behind 
the animals head. The time duration taken for the flinch and flicks were scored.  
Pupillary response assessment  
The pen light was shined in the eyes of the animals. The response to contraction was scored.  
Response to visual stimuli 
The blunt object was approached the animals head and held the object 1 to 2 inch from the animal’s 
head for few seconds. The time duration taken for approaching the object was recorded.  
Tail flick latency assessment  
This method was used to assess the sensor motor status of the animals [133] Response to painful 
stimuli was measured by the tail flick method using analgesiometer. In this the animals were 
exposed to noxious stimulus like radiant heat and tail flick latencies (the time required for the 
flicking of tail i.e. the reaction time and a mean of two pre drug recordings were taken as basal 
value(0minute). A cut off time of 10 seconds was maintained in order to prevent tissue injury 
(based on the reaction time that generally varied between 3-4 seconds).  
Tail pinch response  
This was used to assess the sensor motor activity of the animals and the response to painful stimuli 
was measured in this method. The animal’s tails were lightly pinched approximately 2 inch from 
the tip with the help of forceps. Recordings were noted.  
NERVOUS AND MUSCLE MEASUREMENTS  
Motor coordination assessment  
For the evaluation of coordination and balance, the rotarod test was carried out. The apparatus 
consists of a horizontal metal rod positioned 25cm above a switch floor. The rod was divided in to 
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four parts by plastic plates so that four rats could be tested at a time. Rats were positioned on the 
rod rotating at a constant speed of 20 rpm and the time the rat could stay on the rod without falling 
was recorded [136].  
Locomotor activity assessment  
Locomotor activity is determined by using actophotometer and this is to assess the neuromuscular 
status of the animals. The animals were placed on the digital actophotometer. The locomotion of 
the animals was recorded.  
Righting reflex assessment  
This is also used to assess the neuromuscular status of the animals. In this the animals are placed 
on their back. The ability to regain a position on all four legs was recorded.  
Landing foot splay assessment 
This method was used to assess the neuromuscular status of the animals. The animals were grasped 
by the scruff of the neck and base of the tail. The paws were marked with ink and held above the 
bottom at a height of 1 ft. The animals were released and the distance between the heels was 
measured. The foot play distance was measured.  
BODY WEIGHT  
The body weights were recorded at the study Day 0, weekly during the study and at scheduled 
necropsy.  
FEED AND WATER CONSUMPTION  
Food consumption was assessed on a daily basis by weighing the feeders and expressed as grams 
per rat per day. Water consumption was measured.  
HEMATOLOGY AND BIOCHEMISTRY  
A complete battery of Haematological, clinical chemistry, and urinalysis measurements were taken 
at baseline and during the final week of the study on the animals per sex from each dose group. 
The selected animals were placed in metabolic cages, during which time urine was collected for 
urine analysis. Blood was also collected from the animals for fasting glucose analysis.  
Haematological parameters evaluated included haemoglobin, packed cell volume (PCV); 
erythrocyte count, leukocyte count (total and differential), Mean corpuscular volume (MCV), 
mean corpuscular haemoglobin (MCH), and mean corpuscular haemoglobin concentration 
(MCHC) were calculated and reported. Clinical chemistry parameters evaluated on separated 
Antidiabetic and Toxicity Assessment Of Combination of Piper nigrum And Artocarpus hetrophyllus 
R.V.S College Of Pharmaceutical Sciences, Dept. Of Pharmacology, Sulur, Coimbatore          Page 76 
serum samples included alkaline phosphates (ALP), SGOT, SGPT, Albumin, Protein, glucose, 
urea, creatinine, and serum TSH level.  
All surviving test and control animals were sacrificed at study termination by cervical dislocation 
under anaesthesia and subjected to a complete necropsy. The organs were harvested and weighed 
and relative organ weights (g/kg body weight) were calculated using terminal body weights.  
GROSS PATHOLOGY  
All animals in the study were subjected to a full, detailed gross necropsy which includes careful 
examination of the external surface of the body, all orifices, and the cranial, thoracic and abdominal 
cavities and their contents. The liver, kidneys, adrenals, testes, epididymis, prostate with seminal 
vesicle with coagulating glands as a whole, thymus, spleen, brain and heart of all animals (apart 
from those found moribund and/or intercurrently killed) trimmed of any adherent tissue, as 
appropriate, and their wet weight taken.  
The following tissues were preserved in the most appropriate fixation medium for both the type of 
tissue and the intended subsequent histopathological examination: all gross lesions, brain, liver, 
kidneys, adrenals, spleen, heart, thymus, trachea and lungs (preserved by inflation with fixative 
and then immersion), epididymis, prostate + seminal vesicle, lymph and peripheral nerve.  
Statistical methods  
Body weight data were analyzed using a one-way analysis of variance followed by Dennett’s 
multiple comparison tests P<0.05 was considered to be statistically significant. One-way analysis 
of variance (ANOVA) was used in analyzing body weight change, organ weight, and food and 
water consumption.  
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PHARMACOLOGICAL SCREENING 
Male Swiss albino rats weighing 150-200g were used for the present work. The animals used for 
the experiment were maintained under standard laboratory conditions in an animal house of RVS 
College of Pharmaceutical sciences approved by the committee for the purpose of control and 
supervision on experiments on animals (Ref.No: IAE1012/C/06/CPCSEA) under 12 h dark/light 
cycle and controlled temperature 24±20C. They had free access to food and water ad libitum. The 
animals were acclimatized to the laboratory for a period of 7 days, before the commencement of 
experiment.  
 
ORAL GLUCOSE TOLERANCE TEST [136, 137]  
The ability of an individual rat to handle a standard oral glucose load was evaluated by assessing 
the blood plasma for glucose level. Study on Oral Glucose Tolerance Test (OGTT) initially, 
hypoglycemic activity of herbal formulation was carried out in overnight fasted normal rats, which 
were equally divided into four groups of six rats each. Normal control group received only vehicle 
(1 ml of water) and test group received the formulation in three different dose level ie low, 
therapeutic and high dose respectively. Following 30 min post extract administration all the 
animals were fed with glucose (2 g/kg). Blood samples were collected from tail vein prior to dosing 
and then at 30, 60, 90 and 120 min after glucose administration. The fasting blood glucose level 
was analyzed using glucose-oxidase-peroxide reactive strips (Dr.Morepen Gluco One, Morepen 
Laboratories Limited, Delhi, India).  
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ANTIDIABETIC ACTIVITY 
 
INDUCTION OF DIABETICS [138-140,i]  
Six adult albino rats weighting 170-240 grams  were used for inducing diabetes. The animals were 
injected by Streptozotocin at the dose of 60 mg/kg of the body weight by intraperitoneally 
administration dissolved in freshly prepared 0.01M citrate buffer, pH4.5. Streptozotocin induces 
diabetes within 3 days by destroying the beta cells. Diabetic animals and non-diabetic control 
group were kept in metabolic cages individually and separately and under feeding and metabolism 
control. Glucose in the blood of diabetic rats exceeded that of the non-diabetic control ones. Food 
consumption was measured in terms of (gram), water consumption was measured in terms of (ml) 
and urine volume was measured in terms of (ml) on a daily basis while every 2-4 weeks in 80 days 
the levels of C-peptide, insulin and glucose in blood serum were also measured, so that chemical 
diabetes was verified in rats injected with Streptozotocin  
 
ASSESSMENT OF DIABETIC 
Diabetic was conformed after 48 hr of streptozotocin injection, the blood samples were collected 
through retro orbital puncture and plasma glucose level were estimated by Dr.Morepen Gluco One 
Glucometer. The rat having fasting plasma glucose levels more than 250 mg/dL were selected and 
used for this study. 
PROTOCOL OF EXTRACT ON STREPTOZOTOCIN INDUCED DIABETIC RATS.  
The albino rats on either sex have been selected for the experimental study. The weight should be 
around 170-240 gm. The animals are divided into four groups. Each group has 6 animals. Group 
1 was kept as normal (normal rat) received only distilled water; group 2 was kept as negative 
control, Streptozotocin induced and received only water; Group 3 was treated with glibenclamide 
(60mg/kg) and Group 4 is diabetic induced were treated with 200mg/kg  ethanolic leaves extract 
of  both Artocarpus Hetrophyllus and  Piper Nigrum in the ratio 1:1 dissolved in ethanol (100 mg 
ethanolic leaves extract of Artocarpus Hetrophyllus+ 100 mg ethanolic leaves extract of Piper 
Nigrum dissolved in ethanol) 
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Table 9:-Protocol of Antidibetic Study of Extract 
GROUPS 
 
TREATMENT 
GROUP 1 
 
Normal Control 
GROUP 2 
 
Diabetic Control 
GROUP 3 
 
Diabetic+ Glibenclamide 
GROUP 4 
 
Diabetic+ Extract(200 mg/kg) 
Ethanolic leaves extract (test drug) was administered for 21 days at a dose of 200mg/kg. Dried 
extract dissolved in ethanol given orally. The blood was collected by sinus orbital under the light 
diethyl ether anesthesia. The blood was centrifuged at 3000 rpm for 10 minutes. Body weight 
glucose was analyzed every week and lipid and lipoprotein profile from serum (TC, TG, HDL, 
LDL, VLDL.) were analyzed after 21 days. This protocol performed as per CPSEA Ref No 
1012/06/CPSEA  
 
OBSERVATION  
Serum glucose level estimation (initial and final)  
Body weight of the albino rats (weekly once)  
                                    Water consumption (weekly once) 
                                    Lipid and lipoprotein profile 
 TC 
 TG 
 HDL 
 LDL 
 VLDL 
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7. RESULTS AND DISCUSSION 
 
 
Table 10:- Soxhlet Extraction of the Plants 
 
Plant 
 
Part 
Used 
 
Method Of 
Extraction 
 
 Solvents 
Weight Of 
Powder 
Taken(A) 
Weight Of 
Product 
(B) 
Percentage 
Yield 
( W/V) 
 
Artocarpus 
hetrophyllus 
 
 
leaf 
Continuous Hot 
percolation by 
Soxhlet 
apparatus  
 
 
Ethanol 
(60-80°C)  
 
 
 
500 gm 
  
 
49.4gm 
 
 
9. 88 
 
 
Piper nigrum 
 
 
leaf 
Continuous Hot 
percolation by 
Soxhlet 
apparatus  
 
 
Ethanol 
(60-80°C)  
 
 
 
500 gm 
 
 
78.5gm 
 
 
15.7 
 
                                 A = Weight of powder plant material  
                                 B = Weight of extract       
                                 Percentage yield = (B/A) X 100 
 
DISCUSSION 
The Percentage yeld of Artocarpus hetrophyllus = 9. 88 
The Percentage yeld of Piper nigrum = 15.7 
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PRELIMINARY PHYTO CHEMICAL SCREENING.  
Ethanolic leaf extract of Artocarpus hetrophyllus and Piper nigrum was subjected to various 
chemical test as per the standard methods mention in the chapter no 6 for the identification of the 
various constituents. The result of this phytochemical analysis is listed below.  
 
Table 11:-Qualitative Phytochemical Screening of Plant Extract 
 
Plant constituent 
 
 
Ethanolic Extract of  
Artocarpus hetrophyllus 
 
Ethanolic Extract of Piper  
nigrum 
Steroids - + 
Carbohydrate + - 
Flavonoids + + 
Proteins and amino acids + - 
Glycosides + - 
Alkaloids - + 
Saponins + + 
Volatile oil - - 
Tannins + + 
Terpenoids - + 
 
“+”   -    Presence 
“-”    -    Absence. 
DISCUSSION  
Ethanolic extract of artocarpus hetrophyllus may contain the following phytochemicals 
1. Carbohydrate 
2. Flavonoids 
3. Proteins and amino acids 
4. Glycosides 
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5. Saponins 
6. Tannins 
 
Ethanolic extract of artocar Piper nigrum may contain the following phytochemicals 
1. Steroids 
2. Flavonoids 
3. Alkaloids 
4. Saponins 
5. Tannins 
6. Terpenoids 
TOXICITY STUDIES 
 
ACUTE TOXICITY STUDIES  
 
Acute toxicity studies on the albino rats show no morality at a dose of 2000mg/kg, during a time 
period of 14 days. NOAEL were not seen in the entire study period. This acute study helps to 
predict that it does not contain any type of toxicity and it is full safe. So 100 mg/kg b.w (1/20th) 
and 200mg/kg b.w (1/10th) and 400mg/kg (1/5th) were selected of that dose for the further 
toxicological study. 
SUBACUTE TOXICITY STUDIES  
 In-vivo sub-acute oral toxicity study were performed to evaluate the toxicities of 28 days by 
continuous administration of the prepared extract , as per the procedure mentioned in the section 
6. Daily observations include changes in skin, fur, eyes, mucus membrane (nasal), respiratory rate, 
circulatory signs (heart rate), autonomic effects (salivation, lacrimation, perspiration, piloerection, 
urinary incontinence and defecation), central nervous system (drowsiness, gait, tremors and 
convulsion), body weight and food consumption. The results were summarized in table 12 to 16. 
At the end of the treatment, the animals were bled from the retro orbital sinus for clinical pathology 
assessment which included analysis of various haematology parameters and blood biochemistry 
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parameters. Consequently the animals were sacrificed by cervical dislocation and necropsied to 
facilitate gross pathological examination of organs.  
 
TABLE 12:- EFFECT OF EXTRACT ON STIMULUS RESPONSE 
 
 
Parameters 
 
Observations 
Approach response Slowly approaches, sniffs and pulls 
back/normal 
Touch response 
 
Slowly retreats/normal 
Eyelid response 
 
Blinks/normal 
Pinna reflex 
 
Auricle twitches/normal 
Sound response 
 
Mild reaction, hears sound/normal 
Tail flick response 
 
Flicks the tail or normal 
Pupillary reflex 
 
Contracts 
Righting reflex 
 
Lands on four limbs/normal 
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TABLE13:- EFFECT OF EXTRACT ON AUTONOMIC OBSERVATIONS 
Sl No Parameters Observations 
1 Reactivity Easy/normal 
2 Handling Did not resist, very easy to handle 
3 Palpebral closure Normal (eyes are open) 
4 Lacrimation No lacrimation 
5 Salivation No salivation 
6 Piloerection None/normal 
7 Hair coat Normal 
8 Bite marks None 
9 Nail status Normal 
10 Rearing activity Normal 
11 Clonic involuntary movement None 
12 Tonic involuntary movement None 
13 Gait Normal 
14 Movements Normal 
15 Arousal Normal (keeps guard up and engages in 
exploratory activity) 
16 Stereotype behaviour (preening, squeaking, 
shaking head and other repetitive behavior 
 
None 
17 Abnormal behaviour (squirming, running 
backwards, labored movements, squealing) 
 
None 
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TABLE 14:- EFFECT OF EXTRACT ON NERVOUS AND MUSCLE MEASUREMENTS 
Parameters Observations 
Abdominal tone Normal (proper  hardness) 
Limb tone Normal 
Motor coordination No abnormal changes 
Landing foot splay 
 
No significant difference 
between control 
                         
   TABLE 15:-EFFECT OF EXTRACT ON PERCENTAGE CHANGE IN BODY WEIGHT 
 
 
Sex 
 
 
Dose 
 
Days 
 
0 
 
7 
 
14 
 
21 
 
28 
 
 
 
 
 
Male 
 
Control 
 
129.4±3.26 139.8±2.3  148.2±2.33  158.8±1.85  169.8±3.15 
Lower Dose 167.5±2.82 180±1.69 196±1.63 199.5±2.07 204±2.70 
Middle dose 215.5±2.35 222±4.31 229.5±0.89 235±1.51 231.5±1.59  
Higher Dose 222.5±4.0 217±2.55 227±2.53 231±2.42 227±1.70  
 
 
 
 
 
Female 
 
Control 123.9±3.20  130±3.92  139.4±3.76  150±5.15  160.2±4.32  
Lower Dose 225±2.92  221±2.43  225±4.2  222±4.16  222±3.26  
Middle dose 203±2.92  212±2.43  212±4.2  214±4.16  216±3.26  
Higher Dose 
 
190±2.27  203±2.40  208±2.06  211±2.18  215±1.24  
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FIGURE14:- EFFECT OF EXTRACT ON BODY WEIGHT 
 
  
 
TABLE 16:- EFFECT OF EXTRACT ON RELATIVE ORGAN WEIGHT 
 
Sex  
 
Group  
 
Brain  
 
Heart  
 
Liver  
 
Kidney  
 
 
 
 
Male  
 
 
Control 
1.35±0.12 5.18±.12  5.63±3.4 5.73 ±.43  
 
Low dose  
1.37±0.43 5.20±1.3 5.73±1.22  5.82±.26  
Medium 
dose 
1.34±0.15 5.25±1.3 5.80±3.2 5.90±3.5 
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   High dose 
1.40±2.3 5.28±2.3 5.85±1.2  5.99±4.2  
 
 
 
 
Female  
 
 
Control 
1.50±1.56 5.82±.34  
 
5.83±.45  
 
6.12±1.3  
 
 
Low dose  
1.45±2.34 5.94±1.76  
 
5.92±2.43  
 
6.23±.23  
 
Medium 
dose 
1.40±3.53 6.15±.54 6.12±.4  5.98±2.7 
 
High dose  
1.42±1.43 6.27±.32  
 
5.85±6.3  
 
6.09±6.4  
 
 
 
FIGURE 15:- EFFECT OF EXTRACT ON ORGAN WEIGHTS 
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EFFECT OF EXTRACT ON ORGAN WEIGHTS
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TABLE 17:-EFFECT OF EXTRACT ON SERUM BIOCHEMICAL PARAMETER 
Sex  Group  Days  
 
Hb  g/dl  RBC ×106mm3 WBC×103mm3 
 
 
 
 
 
Male  
 
 
Control  
0 14.2±2.34  5.75±0.67 12.3±0.31  
28  13.9±1.00 5.67±0.32 11.9±.62  
 
Lower Dose  
0 11. 8±2.3 5.9±0.65  11.83±.88  
28  9.3±2.02  4.10±0.60  13.6±.63  
 
Middle Dose  
0 12.0±2.3  5.2±0.45  11.9±.62  
28  14.3±2.54  5.76±4.43  11±2.72  
 
Higher dose  
 
0 11.9±0.57  5.3±0.15  11.6±.32  
28  14.4±2.34  5. 81±0.67  10.7±2.2  
 
 
 
 
 
 
 
 
Female  
 
 
Control 
0 13.3±9.07  5.72±4.54  12.7±4.54  
 
28  
 
14.2±1.00  
 
5.75±0.32  
 
12.3±1.57  
 
 
Lower Dose  
 
0 13.9±2.3  5.73±0.65  11.9±2.2  
28  14.7±2.02  5.9±0.60  
 
12.7±1.52  
 
 
Middle Dose  
 
0 14.7±2.3  5.3±0.88  11.9±2.99  
28  14.5±1.25  5.7±0.45  13.1±8.6  
 
Higher dose  
 
0 
 
12.6±2.54  
 
5.6±0.76  
 
12.2±1.38  
 
28  
 
14.5±0.57  
 
5.9±0.15  
 
12.9±4.2  
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TABLE 18:-EFFECT OF EXTRACT ON SERUM BIOCHEMICAL PARAMETER 
Sex  Group  Days  Serum creatinine 
mg/dl 
Serum SGOT Serum SGPT 
 
 
 
 
 
MALE  
 
Control  
 
0 0.6±0.34  277.3±3.42  103.5±1.21  
28 0.66±0.2 277.9±5.51  103. 8±1.21  
Lower Dose  
 
0 0.67±0.31  270.9±5.34  101. 8±5.64  
28 0.91±7.08  308.1±5.58  114.5±0.23  
Middle Dose  
 
0 0.69±9.89  272.9±0.42  102.8±9.61  
28 0.49± 0.2  298. 8±10.39  120.9±9.61  
Higher dose  
 
0 0.6±12.42  273.7± 0.2  103.5±15.32  
28 .68±14.26  313.6±14.17  116.5±0.28  
  
 
 
 
 
FEMALE  
 
Control  
 
0 0.65±0.44  280.4±1.34  102.9±4.24  
28 0.7±0.4  282.1±5.03  102.9±1.83  
Lower Dose  
 
0 0.63±0.20 276.9±4.13 101.6±4.7  
28 0.9±0.13  290.7±2.2  118.4±4.3  
Middle Dose 
 
0 0.64± 0.42  278.6±6.4  103.6±5.56  
28 0.65± 0.2  300.7±5.4  117.9±4.32  
Higher dose  
 
0 0.64±2.1  274.9± 0.21  103.4±3.3  
28 0.68±0.28   301.3± 0.42  114.6±5.23  
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HISTOPATHOLGICAL ASSESSMENT OF EXTRACT 
Figure 16:- T.S of Rat Liver Showing Normal Cells in Subacute Toxicity Study of Extract 
                                                    
                           Control                                                                     Lower dose  
 
     
                       Medium dose                              Higher dose 
Microscopic appearance-  
 
Section studies from the liver shows normal lobular architecture. Individual hepatocyte, central 
vein and sinusoids shows p- unremarkable. There is no evidence of inflammation and necrosis. 
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KIDNEY 
Figure 17:- T.S of Rat Kidney Showing Normal Cells In Sub Acute Toxicity Studies of 
Extract 
             
                           Control                                                                      Lower dose 
  
             
                         Medium dose                                                                      Higher dose 
  
 
Microscopic appearance 
Section studies from the kidney show normal cortex and medulla. The glomeruli, interstitium and 
blood vessels are unremarkable. There is no evidence of inflammation and necrosis. 
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HEART 
 
Figure 18:- T.S of Rat Heart Showing Normal Cells In Sub Acute Toxicity Studies of Extract 
              
                       Control                                                                       Lower dose 
  
                
                    Medium dose                                                                 Higher dose 
  
 
Microscopic appearance-  
Section studies from the heart shows normal myocardium with myocytes. There is no evidence of 
myocytic degeneration or edema. 
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BRAIN 
 
Figure 19- T.S of Rat Heart Showing Normal Cells In Sub Acute Toxicity Studies of Extract 
             
                       
                     Control                Lower dose  
 
               
                      Medium dose             Higher dose 
 
Microscopic appearance-  
Section studies from the brain shows normal cerebellum. Brain parenchyma, purkinjic cells and 
basal ganglion unremarkable. There is no evidence of inflammation and necrosis 
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DISSCUSION 
In the sub-acute toxicity studies, no animal mortalities were observed in any of the study groups 
throughout the study period. The animals did not exhibit any treatment related abnormal 
behavioural traits. For all the dose level falling in the category NOAEL <100 mg/kg. The 
observations indicated that long-term administration of the extract had no adverse effects on the 
general health of the animals. No significant differences were observed in body weights or food 
consumption of the animals of the treatment groups when compared with that of the control groups. 
Similarly, no significant changes in haematology parameters and blood biochemistry parameters 
of the animals of the treatment groups when compared with that of the control groups. However, 
on completion of the treatment animals were sacrificed, necropsied and pathological examination 
of vital organs such as liver, heart, kidney and brain were performed and result showed that cells 
were within normal 
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ANTIDIABETIC ACTIVITY 
Oral glucose tolerance test  
In the OGTT the extracts at a dose of 200mg/kg significantly reduced the blood glucose level at 
30 minutes after glucose administration. Standard drug glibenclamide produced activity at all the 
time interval tested  
TABLE 19:- ORAL GLUCOSE TOLERANCE TEST OF EXTRACT 
 
Group  
Blood glucose levels (mg/dl)  
0 min  30 min  1st hour  2nd hour  3rd hour  8th hour  
Control  84.5  
± 1.14  
121.4 
± 1.52  
162.91 
± 13.67  
139  
± 2.074  
111.02 
± 5.805  
93.4 
± 1.304  
Glibenclamide 
mg/kg  
87.5  
± 10.164  
70.3 
± 7.19  
84.0 
± 10.271  
83.6 
± 13.342  
81.2 
± 7.791  
80.2 
± 7.328 
Test Extract 
200mg/kg  
85.6 
± 5.263  
83.6 
± 6.894  
83.6  
± 1.924  
90.2 
± 2.408  
80.4  
± 1.517  
84.4  
± 2.302  
 
All value are expressed as mean ± SEM (n=6) 
Figure 20:- ORAL GLUCOSE TOLERANCE TEST OF EXTRACT 
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EFFECT OF EXTRACT ON SERUM GLUCOSE LEVEL 
 
Table 20:- Effect of Extract on Serum Glucose Level in Normal Control and STZ Induced 
Diabetic Rats 
S.NO  TREATMENT                        SERUM GLUCOSE LEVEL  
Initial  7th day  14th day  21stday  28th day  
   1 Normal control  
 
90.9 
±1.47  
94.9 
±1.47  
92.2± 
4.1 
90.3± 
2.13  
91.2 
±2.16  
   2 Diabetic control  
 
91.6 
±1.4  
259.3 
±3.51 
303.3 
±5.5 
375.7 
±1.3 
405.3 
±1.26 
   3 Diabetic+ Standard  
 
94.1 
±1.2 
267.9± 
3.15 
150.3 
±1.4 
130.2 
±0.5 
125.9 
±1.0 
   4 Diabetic+ Extract 
200mg/kg  
93.5 
±1.22  
239.7 
±1.25  
141.1 
±0.7  
124.9 
±1.7  
119.7 
±2.49  
All values are expressed in MEAN ± SEM (n=6)  
 
Figure 21:- Effect of Serum Glucose Level In Normal Control And STZ Induced Diabetic 
Rat 
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EFFECT OF EXTRACT ON BODY WEIGHT 
There was gradual increase in body weight in normal control while the diabetic control continues 
to lose the weight. However treated diabetic group gained 6.25%, 8.24% as compared with the 
diabetic control and diabetic treated towards normal range. Extract changes in the body weight 
shows in the tables.  
Table 21:-Effect Of Extract On Body Weight In Normal Control And STZ Induced 
Diabetic Rats. 
Sl 
No 
 
TREATMENT 
                                BODY WEIGHT  
Initial 7th day 14th day 21stday 28th day  
1 Normal control  242.9±3.5  247.8±1.33  254.1±2.333  263.11±8.5  274±1.95  
2 Diabetic control  248.9±4       
 
221.8±5.55 215.1±2.4 198.1±3.9 189±1.64 
3 Diabetic+ 
Glibenclamide.  
243.5±5      
 
230.2±4.88 245.1±2.3 260.1±1.34 275.8±1.6 
4 Diabetic+ 
Extract 200  
243.2±25      
 
228.1±4.6 245.1±3.4 260.5±6.7 282.8±2.7 
                           All value are expressed mean ±SEM (n=6) 
                            P<0.001, as compared to diabetic control  
                            P<0.001 as compared to Normal control. 
Figure 22:- Effect On Extract on Body Weight 
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8. SUMMARY AND CONCLUSION 
 
Phytochemical screening  
Qualitative Phytochemical screening and ethno botanical survey on the Artocarpus 
Hetrophyllus Leaf extracts the presented of certain phyto constitutions such, Proteins and amino 
acids, tannins, flavonoids, carbohydrates, glycosides, terpenoids. 
Qualitative Phytochemical screening and ethno botanical survey on the Piper Nigrum Leaf 
extracts the presented of certain phyto constitutions such steroids, tannins, flavonoids, 
carbohydrates, alkaloids, terpenoids  
The phytochemical constituents such as glycosides, tannins, alkaloids, triterpenoids, and 
flavonoids may be linked to the anti diabetic activity.  
 
Acute toxicity studies  
To check the safety profile of the combination of the leaf extract of Piper Nigrum and 
Artocarpus Hetrophyllus in the ratio of 1:1, it was subjected to the acute toxicity study which 
conformed the absence of any toxicity or mortality at the higher dose of 2000mg/kg. Thus the 
Extract can be classified as a safe drug category according to the Global harmonized Classification 
System quoted in the OECD guidelines 1996.  
             Based on the Toxicity studies 100mg/kg is used as a dose of extract and middle dose 
200mg/kg and higher dose as 400mg/kg used for sub-acute toxicity studies.  
 
Sub-acute toxicity studies  
Sub-acute toxicity study was done and the results shows nontoxic nature for the Extract. 
Also, all the animals from control and all the treated groups up to dose 400 mg/kg survived 
throughout the dosing period of 28 days. Animals from all the treated groups exhibited comparable 
body weight gain with that of controls throughout the dosing period. No significant changes in the 
organ weight were observed. Furthermore no specific cell damage was noticed by the microscopic 
examination. The central and autonomic profiles were normal throughout the study and no specific 
alterations were noticed.  
              The results of the effect of the extract on the body weight of the animals compared with 
vehicle are as shown in Table 15 and Fig. 14. There were no significant increases in the weight of 
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animals treated with 100 mg of extract However, there were little amount of weight reduction body 
weight in middle dose and higher dose treated animals. 
The results of the effect of Extract on absolute organ weights of male and female rats are 
as shown in Table 16. Macroscopic examination did not show any changes in the colour of organs 
of the treated animals compared with vehicle. There were no significant changes in the relative 
weights of the liver, kidney and heart in both males and females. Treatment had no effect on spleen, 
stomach and testes of male rats. 
Hematological analysis and Biochemical analysis conducted at the end of the dosing period 
revealed no abnormalities attributable to the treatment.  
 
Effect of Extract on blood sugar level  
Streptozotocin treatment will produce significant increase in serum glucose level with 
respective normal control group. The administration of Extract 200 mg/kg and glibenclamide 0.6 
mg/kg significantly reversed the increase in serum glucose concentration in Streptozotocin induced 
rats. The extract changes in the serum glucose level are shown in the table 20.  
Diabetic mellitus (DM) is an endocrine disorder in which the glucose metabolism is impaired 
because of total loss of insulin after destruction of pancreatic beta cells or because of inadequate 
release of insulin from the pancreatic cells of beta cells. The fundamental mechanism underlying 
hyperglycemia involved over population and decreases utilization of glucose by the tissue.  
 
Streptozotocin a beta cytotoxic induces diabetic in a wide variety of animal species including rats 
by selectively damaging the insulin secreting beta cells of pancreas i.p injection of STZ produces 
fragmentation of DNA of beta cells of pancreas which stimulates poly (ADP ribose and deflects 
NDA ultimately leading of destruction of beta cells and it is evidenced by clinical symptoms of 
hyperglycemia. 
 Dose dependent of the effect of the glibenclamide showed rapid normalization of blood glucose 
due to its insulin releasing effects. 
In our present study there was a significant weight gain Extract treated the diabetic rats compared 
with the normal control rats and this observation shows anabolic effect of the Extract on body 
weight on the diabetic rats. 
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Hyperglycemia and insulin resistance both seem to have important in the pathogenesis of macro 
vascular complications. Diabetes mellitus causes a disturbance in the uptake of glucose as well as 
glucose metabolism. The hyperglycemia in the diabetes might inhibit tissue repair in the macro 
vascular beds. In the present study of Extract treated group shows hypoglycemic activity and it 
confirms the presence of the anti- diabetic activity. Sulfonylurea such as glibenclamide is often 
used as a standard drug in the STZ induced diabetic to compare to the efficacy of 
antihyperglycaemic compound. In study there was a significant elevation in blood glucose level in 
the diabetic control group as compared with normal animal. The Extract treated group exhibited 
significant reduction of fasting plasma glucose level as compared to the diabetic control group. 
Over production of glucose by means excessive hepatic glycogenolysis and gluconeogenesis is 
one of the fundamental basis of hyperglycemia in diabetes mellitus.  
Diabetes is a common chronic ailment for which the patient has to take insulin to maintain the 
blood sugar level. It is interesting to see how the Extract tackles this problem. It corrects the 
function of pancreas, stimulating it to produce insulin in the natural way, which in turns way to 
maintain the blood sugar level. Extract revitalizes and rejuvenates the organs, the dysfunction of 
which is causing the disease. This bring back normal functioning of the organs. It is also 
maintaining the healthy state body. Since no artificial chemical are involved, it doesn’t cause any 
side effects 
  
CONCLUSION 
 
The presented study is an attempt to investigate the effect of ethanolic extract of the combination 
of the leaf extract of Piper Nigrum and Artocarpus Hetrophyllus in the ratio of 1:1 on 
Streptozotocin induced diabetic in albino rats.  
The Phytochemical study was screening showed the presence of tannins, carbohydrate, Flavonoids 
and reducing sugar which is responsible for the anti-diabetic activity.  
The animals were induced with STZ at a dose of 60mg/kg intraperatoneal and the diabetic animals 
were treated with Extract at a dose of 200mg/kg for 28 days orally. The serum glucose, body 
weight were measured which show significantly increased when compare with positive control 
group.  
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The finding of the presence investigation suggests the Extract has potential for its evaluation as 
protective agents against toxicity induced by Streptozotocin.  
Mechanism of the extract is not completely established which may further done for protective 
action in the future studies 
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